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ABSTRACT 
Microbial competition is a mechanism that occurs when two or more microbial species 
compete for ecological niches to support their survival and growth. Different factors can 
contribute to the outcome of microbial competition, such as molecules exchanged 
between the competing organisms for the regulation of cell densities and the initial 
spatial configuration of the microbe–microbe interaction. Specifically, production of 
compounds that kill or limit the growth of competing strains or species can promote 
niche monopolization [2]. The released compounds include secondary metabolite 
antibiotics, bacterial peptides or low-molecular-mass organic compounds. The same 
happens in food, and it could be possible to explore this 'molecular' communication to 
improve food safety. In that sense, it is very important to develop tools in the control of 
bacterial species for a better food safety. The present work focused on the study of 
microbial competition between Listeria monocytogenes (LM) and Lactococcus lactis 
(LAC) monitored through proteomics, peptidomics and metabolomics approach. We 
study the secretome of these two microorganisms (Listeria monocytogenes and 
Lactococcus lactis) alone and in co-culture. In particular, we studied by proteomic 
analysis the evaluation of proteins secreted by bacteria through one/two-dimensional 
electrophoresis coupled to mass spectrometry (MALDI TOF). Furthermore, in order to 
characterize each secretome, label free Shotgun analysis was conducted using nano 
UPLC-MS system. Furthermore, the secretome of these microorganisms has been 
studied through first an untargeted proteomics analysis in vitro, followed by validation 
directly in a system resuming cheese. The objective of the last part of the project has 
been the monitoring of bacterial competition between through a combination of 
microbial Imaging mass spectrometry and LC-MS/MS, in order to investigate the 
metabolic profile of each bacteria in the interacting microbial colonies. In according with 
obtained preliminary data (one-dimensional and two-dimensional electrophoresis), new 
data highlighted, during competition, the higher production by Listeria monocytogenes 
of moonlighting protein Enolase (C1KY94) and Glucose 6 Phosphate isomerase 
(Q71X61), of Septation ring formation regulator EzrA (B8DHE7), involved into cell 
replication in regulatory mechanisms of cell energetics or metabolism and the lower 
secretion Endopeptidase P60 (P21171), protein associated with the cell surface and 
involved in the process of invasion. In parallel, L. lactis produced higher amounts of 
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Secreted 45 kDa protein and switched from lantibiotic Nisin A production to Nisin Z 
production. In competition with LM, LAC strain investigated produce higher amounts of 
Secreted 45 kDa protein with peptidoglycan lytic activity and the selective secretion of 
Nisin Z probably to improve lantibiotic solubility in less acidic environment. Lastly, IMS 
analysis revealed several interesting compounds during interaction of microbial 
colonies. At least six compounds are uniquely expressed during the interaction between 
LM and LAC. Among these, we focused our attention on three compounds: Cyclo-(Leu-
leu), Cyclo-(Phe-Tyr), Cyclo-(L-Phe-L-4-Hyp). These compounds are cyclic peptides, 
isolated by Lactobacilli, with a biological activity]. In particular, they play an important 
role in bacterial cell to cell communication. Probably, these peptides have a role in 
inducing of the transcription of gene coding for Nisine. These results could be useful to 
setup new molecular strategies in the control of bacterial species for a better food 
safety. 
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ABSTRACT 
La competizione microbica è un meccanismo che si verifica quando due o più specie 
microbiche competono per la conquista della nicchia ecologica per la loro sopravvivenza 
e per la loro crescita. Diversi fattori possono influenzare la competizione microbica, 
come ad esempio lo scambio di molecole tra gli organismi che competono per la 
regolazione della densità cellulare e la configurazione spaziale dell’interazione microbo-
microbo. In particolare, la produzione di molecole in grado di uccidere gli organismi 
competitor, limitandone la crescita o modulandone il metabolismo potrebbe avere un 
ruolo chiave nei meccanismi di competizione, antagonismo e di autodifesa nei confronti 
dei microrganismi competitor per consentire al microrganismo di occupare la nicchia e 
utilizzarne i nutrienti. Le molecole rilasciate includono metaboliti secondari, peptidi e 
molecole organiche a basso peso molecolare. Lo stesso accade nei prodotti alimentari, 
ove potrebbe essere possibile esplorare questa comunicazione 'molecolare' in modo da 
migliorare la sicurezza alimentare. In questo senso, è molto importante sviluppare 
strumenti nel controllo delle specie batteriche per una maggiore sicurezza alimentare.  
Il presente lavoro è focalizzato sullo studio della competizione microbica tra Listeria 
monocytogenes (LM) e Lactococcus lactis (LAC), monitorata attraverso un approccio 
proteomico, peptidomico e metabolomico. Nella fase sperimentale, si è studiato il 
secretoma di questi due microrganismi (Listeria monocytogenes e Lactococcus lactis) 
nella condizione di monocoltura e in co-coltura. In particolare, i filtrati cellulari dei vari 
gruppi sperimentali sono stati analizzati mediante elettroforesi mono/bidimensionale 
accoppiata a spettrometria di massa (MALDI TOF). Al fine di caratterizzare al meglio 
ciascun secretoma è stata condotta una analisi di proteomica “shotgun” mediante nano 
UPLC-MS system. Successivamente, il secretoma di questi microrganismi è stato studiato 
mediante un fine analisi di proteomica “untargeted” direttamente nella matrice 
alimentare latte, mediante analisi label free-shotgun con le stesse condizioni 
sperimentali utilizzate per i terreni. 
L'obiettivo di questa ultima parte sperimentale del progetto è stato il monitoraggio del 
meccanismo della competizione batterica attraverso la combinazione di tecniche di 
spettrometria di massa Imaging e analisi LC-MS/MS, al fine di studiare il profilo 
metabolico batterico direttamente nelle colonie microbiche interagenti.  
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In accordo ai dati preliminari ottenuti (elettroforesi mono/bidimensionale), l’analisi 
shotgun sul filtrato cellulare ha confermato, nella condizione di competizione, una 
maggiore produzione da parte di Listeria monocytogenes delle “moonlighting protein” 
Enolasi (C1KY94) e Glucosio 6 fosfato isomerasi (Q71X61) e della proteina regolatrice 
EzrA (B8DHE7), coinvolta nella replicazione cellulare e nei meccanismi di regolazione del 
metabolismo cellulare, e una minore secrezione della proteina Endopeptidasi P60 
(P21171), proteina implicata nella virulenza di Listeria. 
In parallelo, nella condizione di competizione con LM, L. lactis produce una maggiore 
quantità della proteina Secreted 45 kDa con attività peptidoglicano litica e una 
secrezione selettiva della nisina Z. Nell’analisi shotgun è stato confermato che L. lactis 
cambia lo spettro della Nisina in competizione con Listeria che da Nisina A passa nella 
sua variante Nisina Z, probabilmente per maggiore solubilità in un ambiente meno 
acido.  
Infine, l'analisi IMS ha rivelato diversi composti interessanti durante l'interazione delle 
colonie microbiche. Almeno sei composti sono espressi in modo univoco durante 
l'interazione tra LM e LAC. Tra questi, abbiamo concentrato la nostra attenzione su tre 
composti principali: ciclo- (Leu-Leu), ciclo- (Phe-Tyr), ciclo- (L-Phe-L-4-Hyp). Questi 
composti sono peptidi ciclici con attività biologica, isolati da Lattobacilli, e svolgono un 
ruolo importante nella comunicazione batterica cellula-cellula. Probabilmente, questi 
peptidi svolgono un ruolo nell'induzione della trascrizione del gene che codifica per la 
Nisina.  
Questi risultati potrebbero essere utile per il set-up di nuove strategie molecolari nel 
controllo delle specie batteriche per una maggiore sicurezza alimentare 
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1  INTRODUCTION 
The guarantee of food safety during whole shelf-life of products has become the subject 
of great challenge for food industry due to current trends adopted by the modern 
consumer. To date, the consumer requires high-quality foods, foods able to have a long 
shelf-life and all that possibly avoiding the use of chemical compounds. All of these 
factors underlined the need for reliable techniques to monitor developments in food 
science and technology and to evaluate the quality and food safety. In order to put 
these demands into practice, it has become necessary to develop high-throughput 
methods such as proteomics to accomplish this. 
Food safety its might be implicit in the broader concept of food security. Food security 
involves three process steps: availability of food, overall access to the available food, 
proper use of the accessed food. Food security, safety, and quality are important for the 
rising population due to the increasing storage time of food, from vegetables to meat 
and fruit[1]. In recent years, food safety is an increasingly broadening concept which 
encompasses mainly three main areas: (1) food quality (food composition); (2) 
traceability (food origin); (3) food safety per se (absence of allergens, pathogens or 
other contaminants)[2]. Indeed, food safety is not only a matter of determining the 
origin of a product, but it is also matter of evaluation of food edibility through 
biochemical assessment of product purity, both under a chemical and microbiological 
standpoint.  
Proteomics has recently found several applications in the monitoring of food safety. 
Indeed, several aspects can be monitored through proteomics: food quality, traceability, 
safety in the view of the improvement of public health, so from traceability to the 
determination and positive selection of those quality trait that confer resistance to 
abiotic stress such as cold, osmotic stress. Proteomics, metabolomics methods are 
presented as effective tools for identification of cellular biomarkers for adaptive 
behavior of pathogenic microorganisms under different conditions such as cold and heat 
stress, osmotic, high hydrostatic pressure, and other stress factors. 
Another important aspect is the application of proteomics to the assessment of the 
principle of substantial equivalence between food from genetically modified plants and 
wild type counterpart. The sensitivity and specificity of the mass spectrometry method 
based proteomics approaches allows for revealing traces of contaminating agents, such 
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as E.coli bacteria in soybean sprouts [2]. Proteomic integrated approaches offer 
considerable opportunities to assess production and monitoring of quality and safety of 
food, and proteome analysis of pathogens and infected food provides reliable 
information about pathogen activities during infection, outbreak of disease, and 
recovery period. Pathogen survival and growth on food produce is influenced by number 
of independent factors such as storage temperature, nature of the product, processing 
operations and methods, and packaging. The natural microbiota present on products is 
an additional relevant factor for pathogen survival.  
Important applications of proteomics to food quality are focused on the studies of meat 
and dairy product quality. About these foods, proteomics has been used for the 
characterization of taste, flavor, and consistency that represents the pure qualitative 
traits of food products. 
As a matter of the fact, it is mandatory for prevention and control of infectious diseases 
to have facilities that are able to quickly produce reliable, highly specific and sensible 
tools that allow on one hand and adequate sanitary surveillance and to obtain effective 
operative tools. Proteomics constitutes a very important approach to integrate with the 
prevention and control of infection diseases and in particular of the sanitary 
emergencies and food safety linked to animal health.  
In the last few years, microbial proteomics becomes the hard-core junction made by the 
thematic nodes of sanitary emergencies for human health [1]. Microbial proteomics is 
opening up new possibilities in the study of disease pathogenesis, in animal welfare, in 
novel diagnostic and therapeutic markers and in the risk assessment [3]. Microbial 
proteomics is one of the best tools to control emerging diseases and zoonoses to 
improve human health and welfare.  
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Figure 1 An experimental workflow illustrating how proteomics can be applied to food safety[3] 
 
The bacterial competition is a mechanism that tends to eliminate one of the populations 
from their common habitat, especially when competition is focused on a single resource 
and when the populations do not otherwise interact[4]. The same happens in food, and 
it could be possible to explore this social communication to improve food safety. 
The choice of Listeria monocytogenes is because it causes one of the most serious 
foodborne diseases. Listeria monocytogenes (LM) is a Gram-positive foodborne 
pathogen that can contaminate many food products, such as meat, milk, cheese, ice 
cream, raw vegetables, and muskmelon[5].  
LM is foodborne pathogen extremely hazardous for human population that usually 
affects high risk patients such as the elderly, immunosuppressed patients and pregnant 
women. However, it can also affect people who do not have these risk factors. A 
peculiar property of L. monocytogenes that affects its foodborne transmission is the 
ability to replicate at low temperatures. The bacteria may therefore grow and 
accumulate in contaminated food stored in the refrigerator. Indeed, in the spreading of 
this pathology, milk and dairy products often represent a key point as reservoir for this 
pathogen[6].  
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For these reasons, it is mandatory to counteract the Listeria growth in food, avoiding the 
use of chemical compounds. One of the strategies that could be used is based on the 
selection of specific strains of starter bacteria (Lactococcus lactis) able to counteract 
Listeria growth. The use of lactic acid bacteria (LAB) with their inhibitory activities 
against pathogenic and spoilage microorganisms in food [7, 8] could represent a solution 
to this problem. 
Lactic acid bacteria (LAB) are bacteria naturally present in food, used for the natural 
fermentation of products because they are capable to preserve the organoleptic and 
physical characteristic of the food products and confer them a beneficial effects like 
suppression of growth of pathogens[8]. For these abilities, several LAB strains are used 
in dairy industry as starter cultures. 
It is well known as different strains of lactic acid bacteria (LAB) are able to influence the 
growth of these pathogens with several mechanisms of action[9].  
The first is called "Jameson effect", according to which the population that first reaches 
the stationary growth phase locks the population competitor prevent it from increasing 
its concentration[10]. Lactic acid bacteria, present in high concentration, very quickly 
reach their stationary phase of growth by preventing the growth of pathogenic 
microorganism, probably in much lower concentrations in the product. High counts of 
starter bacteria would also implicated in rapid use of nutrient sources (eg. lactose in 
dairy); competition for nutrients. The influence on growth of pathogens can be 
production of lactic acid, which causes a decrease in pH enough to inhibit some strains, 
and also its non-dissociate form causes a reduction of internal pH in sensitive bacteria 
that produces a collapse in the electrochemical proton gradient resulting in a 
bacteriostatic or bactericidal effect[11, 12]. 
In addition to the production of organic acid, such as lactic acid and acetic acid, LAB 
produce diacetyl, hydrogen peroxide and some polypeptides, called Bacteriocins. 
Bacteriocins are ribosomally synthesized antimicrobial peptides[13] produced by 
bacteria which enhance their ability to control food-borne pathogens such as 
Clostridium botulinum, Staphylococcus aureus and Listeria monocytogenes[14, 15].  
Nisin A is the first to be discovered [16] and other natural variants of this protein are F, Q, 
U and Z[17]. The production of bacteriocins by some species of Lactococcus lactis could 
play a key role in pathogens growth inhibition[18].  
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Another way, documented by scientific studies, is the evaluation of the effect of 
metabolites of LAB against several bacterial populations. An attractive hypothesis suggests 
that microbes regulate and optimize their production of such molecules to kill, limit the 
growth of or modulate the metabolism of potential niche competitors for maximal 
advantage. Different factors can contribute to the outcome of microbial competition, such 
as molecules exchanged between the competing organisms for the regulation of cell 
densities and the initial spatial configuration of the microbe–microbe interaction. 
Specifically, production of compounds that kill or limit the growth of competing strains or 
species can promote niche monopolization[19] 
The released compounds include secondary metabolite antibiotics, bacterial peptides or 
low-molecular-mass organic compounds. Specialized metabolites are small molecules that 
are not directly involved in the normal growth, development, or reproduction of an 
organism. They play an important role in mechanisms that bacteria used to alter the 
physiology of neighboring organisms in order to monopolize the ecological niche. These 
metabolites represent the key components in cell-cell interaction. Therefore, the study of 
these compounds and molecular pathway directly involved in the production could be 
useful to fully understand molecular interactions that are the basis of the microbial 
competition between Listeria monocytogenes and Lactococcus lactis. 
The use of LAB as producers of antimicrobial substances, especially bacteriocins, is a 
promising advance for the food industry, for improving the safety of food products, 
extending shelf life and ensuring the health of the consumers. The spectrum of 
antibacterial activity of LAB strains has the potential to cover a very broad ﬁeld of 
application in the food industry.  
Therefore, it is desirable to continue to expand our understanding of the effectiveness 
of the use of naturally occurring antimicrobial molecules the inﬂuences that 
environmental factors have on the implantation and survival of bacteriocinogenic strains 
and the activity of their bacteriocins in order to quantitatively estimate their efﬁcacy for 
future applications in food model systems and establish adequate means of application 
of these bio preservatives. The use of competitive microbiota as a biotechnological tool 
for food preservation may lead to improve the optimization and quality assurance of 
food products while at the same time retaining the sensory qualities of the product such 
as color, ﬂavor, texture and nutritional value.  
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The objective of this project is the study of the molecular mechanisms of bacterial 
competition to improve food safety and the quality of the end products through the use 
of omic tools. In detail, the aim of the work is the monitoring of bacterial competition 
between Listeria monocytogenes and Lactococcus lactis in order to highlight 
mechanisms of bacterial competition involved in this process.  
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1.1 General characteristics of Listeria monocytogenes  
The genus Listeria includes six species: Listeria monocytogenes, Listeria innocua, Listeria 
ivanovii, Listeria grayi, Listeria welshimeri and Listeria seeligeri. Within these six species, 
only Listeria monocytogenes and L. ivanovii are pathogens, but only the former is fatal 
for humans, while the second one regards ungulates[20]. Listeria monocytogenes is a 
Gram-positive, non-spore forming, facultative anaerobic, catalase positive and oxidase 
negative rod shaped bacterium. It belongs to the Firmicutes and due to its characteristic 
low percentage of guanine/cytosine bases in its genome, it is closely related to Bacillus, 
Staphylococcus, Streptococcus and Clostridium species. As a matter of fact it belongs to 
Bacilli class and Bacillales order. Cells are found as a single units, short chains or 
arrangend in V and Y forms[21] . They have peritrichous flagella, which give them a 
characteristic tumbling, motility, occurring only between 20 and 25°C. In Brain Heart 
Infusion (BHI) agar, the colonies are 0.2-0.8 mm in diameter, smooth, punctiform, gray 
and translucid. L. monocytogenes is ubiquitous and  widely present in plant, soil, silage, 
sewage, water and faeces of human and animals. Even if its primary environment is 
considered to be soil, where it lives as a saprophyte feeding off dead and decaying plant 
matter[22], L. monocytogenes can adapt to live in the cytosol of eukaryotic host cells. 
Indeed, following its ingestion by a susceptible individual, L. monocytogenes is capable 
of making the transition to a physiological state that promotes bacterial survival and 
replication in the host cells[23]. As above reported, L. monocytogenes contaminates 
foods because of its ability to survive in food processing plants, where it can resist to 
several adverse conditions including also environments specifically planned to inhibit 
bacterial growth. Although its optimum temperature is 37 °C, it is able to grow between 
-0.4 and 50 °C. Also the pH range is wide (5.6 – 9.0) and it grows in the presence of NaCl 
concentrations up to 10% and at water activity (Aw) values below 0.93 [21].  
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1.2 Mechanism of virulence  
Considering the prevalence of L. monocytogenes in foods and numerous epidemiological 
data reported in the literature, it is established that the main way of introduction of L. 
monocytogenes in humans is through ingestion of contaminated food. The infectious 
process evolves in pathology when the bacterium spreads through the intestinal barrier 
and the blood-borne lymphatic initially reaching the liver, where it multiplies in 
hepatocytes, and the spleen, so bloodborne reaches the secondary target organs: brain 
and placenta. Characteristic of Listeria monocytogenes is its ability to cross host barriers 
(intestinal, blood-brain, maternal-fetal) and exceed the bactericidal mechanisms 
implemented by macrophages as well as to penetrate, by its nature of facultative 
intracellular pathogen, not necessarily within phagocytic cells (hepatocytes, neurons, 
etc.).  
Several mechanisms are adopted by Listeria monocytogenes in order to escape the 
unfavorable conditions of the environment and survive in the gastric human gut before 
spreading intra- and inter-cellular. The antacid therapy taken by some individuals and 
sometimes the same buffering capacity of certain foods, the vehicle of infection, 
temporarily reducing gastric acidity favorably affect the chances of survival of the 
pathogen in these districts and have predisposing factors to manifest the disease or 
establishing the individual condition of asymptomatic carrier [24, 25].  
Generally, L. monocytogenes adopts other enzymatic mechanisms in order to escape 
unfavorable condition. The first mechanism adopted by the bacterium in very low pH 
conditions is the use of glutamate decarboxylase (GAD) system that converts an external 
glutamic acid molecule to the cell in a gamma-hydroxybutyric acid (GABA), using a 
proton inside. The final result is to engage a large number of protons decreasing their 
intracellular concentration, alkalinizing the same time the external medium considered 
the lower acidity of GABA compared glutamic acid [26]. The second known mechanism 
called BSH (Bile Salt Hydrolase, hydrolysis of bile salts), is the enzyme system through 
which L. monocytogenes is capable of hydrolyzing the amide bond of the conjugated bile 
salts. Hence bile acids are released with an emulsifying power lower compared to the 
first, and ,consequently, with lower bacteriostatic and bactericidal effect[26] 
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1.2.1 Pathogenesis 
The bacterial population that survives in these extreme conditions can affect the host 
because of its ability to cross the intestinal, the blood brain and fetal-placental 
barriers[27]. The first mentioned passing is the most important one in listeriosis foods 
infections . Inside the host cell L. monocytogenes has a specific intracellular life cycle 
[23]:  
1) Internalization: it is the first step through which Listeria adheres to the surface of a 
eukaryotic cell and then penetrates into the host cell. During the invasion, a zipper-type 
mechanism is involved, in which the bacterium gradually sinks into dip-like structures of 
the host cell surface until it is finally engulfed. Hence, the membrane of the target cell 
closely surrounds the bacterial cell. The structures, mechanisms, and signal transduction 
cascades involved in the interaction between Listeria and the host cell during 
phagocytosis are not yet totally elucidated. In literature, some surface proteins such as 
the internalin A (InlA) and internalin B (InlB), Ami protein, the actin-polymerizing protein 
ActA, and p60 are recognized as bacterial ligands responsible for adhesion and 
phagocytosis. About 25 internalins are identified in Listeria, and the InlA InlB are the 
best characterized ones. InlA plays a fundamental role in the invasion of L. 
monocytogenes and in particular allows to enter the human intestinal epithelial cell line 
Caco-2 by binding the host cell adhesion transmembrane glycoprotein named 
Ecadherin[28]. The binding between Listeria and the E-cadehin activates a complex 
sequence of events which lead to the depolymerisation of the actin and subsequent 
envelopment of the bacterium with the membrane of the host cell [29]. Hence L. 
monocytogenes enters the host cell within the phagosomal compartment. InlB allows 
the bacterium to invade hepatocytes cells by binding to Receptor Tyrosine Kinase (RTK) 
Met [30]. The RTK Met receptor consists of a single hydrophobic transmembrane-
spanning domain, an extracellular N-terminal region, and an intracellular C-terminal 
region. The link between InlB and the extracellular part of the RTK Met causes the rapid 
tyrosine phosphorylation via the classical phosphatidylinositol 3 kinase pathway (PI3K) 
and triggers signaling pathways leading to actin cytoskeleton integration required for 
internalization of L. monocytogenes. Other proteins including Gab1 and CrkII can 
promote actin polymerisation.  
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2) Escape from primary phagosome: during the invasion, L. monocytogenes is 
internalized in a primary phagosome, but in order to survive and proliferate it needs to 
internalize in a primary phagosome, but in order to survive and proliferate it needs to 
escape from this confinement. Little is known about the characteristics of the Listeria-
containing vacuolar compartment, but the vacuoles become acidified soon after uptake. 
About 30 min after its entry, L. monocytogenes starts to destroy the phagosome 
membrane and exits in the cytoplasm. This membrane disruption is mediated by the 
hemolysin in combination with phospholipases. Hemolysin, or Listeriosin O (LLO), is a 58 
kDa protein belonging to a family of cholesterol dependent cytolysins which is encoded 
by the hly gene and regulated by PrfA, a central temperature sensitive regulator of 
virulence genes [31]. LLO is activated by thiol reducing agents and is inactivated by the 
binding of cholesterol [32], and its function is to form pores into the membrane. It plays 
an important role also in the internalization and host cell interaction. LLO can interfere 
with host cellular mitochondria in order to preserve L. monocytogenes replication by 
inhibiting the death of host cells or killing agents which are inhibitory to bacterial 
dissemination[33]. The phospholipases involved in the membrane disruption are: PI-PLC 
encoded by plcA gene and PC-PLC encoded by plcB [22]. The first one is highly specific 
for phosphoinositol and glycosyl-PI-anchored proteins, while the second one hydrolyses 
a great deal of phospholipids[34]. These proteins work synergistically with LLO causing 
the dissolution of the plasma membrane [35]. 
3) Intracellular growth: After escaping from the primary phagosome, L. monocytogenes 
actively multiplies in the host cytoplasm with a doubling time of approximately 1 h. 
Since the environment is permissive, L. monocytogenes does not use any stress 
response mechanism and three metabolic genes (purH, purD, and pyrE, involved in 
purine and pyrimidine biosynthesis) and an arginine ABC transporter (arpJ) are induced 
within host cells. The mutation of these genes can be involved in metabolic pathway in 
order to improve the growth within cells. Indeed, a study indicates that pathogenic 
Listeria spp. may exploit hexose phosphates from the host cell cytoplasm for an efficient 
intracellular growth [36].  
4) Movement and spreading to adjacent cells: intracytoplasmic L. monocytogenes is 
surrounded by a dense cloud, formed by host cell actin filaments, which polymerises to 
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form an actin tail on one bacterium pole. This tail is composed by two cross-linked actin 
filaments and let bacterium to move quickly (0.3 mm/s) inside the host cell to infect the 
new cytoplasm. When bacterium comes into contact with the membrane, push it as a 
rocket and a sort of finger-like protrusion with a bacterium at the tip is generated. Later 
this protrusion penetrates in the neighboring cell and is “swallowed”. the dissolution of 
the plasma membrane[35].  
5) Escape from secondary phagosome: Inside the new cell, L. monocytogenes is in turn 
engulfed by a second phagosome delimited by a double membrane with the inner 
membrane originating from the donor cell. L. monocytogenes rapidly escapes from the 
new formed vacuole by dissolving the double membrane, thus reaching the cytoplasm 
and initiating a new round of intracellular proliferation and direct intercellular spread. 
The actin-based intracytoplasmic movement and cell-to-cell spread are mediated by the 
surface protein ActA. ActA id encoded by the ActA gene and is a 639 amino acid, 
dimerised protein which is formed by three distinct parts [37]. The N terminus is 
associated with actin assembly and bacterial motility; the central part is responsible for 
the connection between protein and the bacterial cell wall, while the VCA region 
interacts with the Arp2/3 complex. Arp2/3 is another protein complex which facilitates 
the polymerisation of actin [38]. The polymerization involves other proteins such as 
VAPS and CapZ. These proteins mediate also the evasion of L. monocytogenes by the 
host cell.  
A correct evolution of these steps is fundamental for a full L. monocytogenes virulence 
and defects at any point can lead to high attenuation. In Figure 1.2-1 the intracellular 
cell cycle is reported. Almost all genes reported before, and involved in the invasion, 
primary phagosomal escape and direct cell to cell transmission, are regulated by the 
PrfA protein. In particular prfA, plcA, plcB, hly, mpl, actAB and hpt are under the control 
of this protein. PrfA is a 233 amino acid long, which up-regulates these gene when 
Listeria is in a host cell and down-regulates them when it lives in the environment. The 
expression of the PrfA protein is temperature dependent: It is silent at 30°C and 
maximally expressed at 37°C[39]. In this way PrfA controls the virulence genes at the 
homeostatic temperature of the host cell.  
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 Figure 1.2-1. Intracellular cell cycle of L. monocytogenes [22] (Nancy E. FREITAG et all, 2009). 
Page 21 of 114 
1.3 Listeria monocytogenes metabolism  
L. monocytogenes can live and grow under both aerobic and anaerobic conditions. Most 
of its metabolic pathways are similar to those of Bacillus subtilis, which belongs to the 
group of low G+C Gram-positive bacteria similarly to L. monocytogenes. Neverthenless, 
there are various significant differences which may be essential for understanding the 
interference of listerial metabolism with that of the host cells[40]. In aerobic conditions,  
the respiration takes place and the respiration chains contains (as quinones only) 
menaquinone, but not coenzyme Q10, also called ubiquinone[40]. Menaquinone derives 
from a branch of the aromatic amino acids pathway and it functions as a cofactor in the 
electron transport chain. In aerobic conditions Listeria spp. uses hexoses and pentoses 
to grow, including maltose, glucose, rhamnose and lactose, but not sucrose[41]. The 
main metabolic end products in aerobic conditions are lactate (28%), acetate (23%) and 
acetoin (26%)[42]. Under anaerobic conditions, only hexoses and pentoses support 
growth. In particular lactate is the major fermentation product (about 79%) thus 
indicating that the mixed acid fermentation is the major mode of fermentation in L. 
monocytogenes[41]. Other anaerobic end products have been found which include 
formate (5.4%), ethanol (7.8%), carbon dioxide (2.3%) and acetate (2%)[43]. These 
results demonstrate that acetoin and lactate are good indicators of aerobic or anaerobic 
growth. Concerning carbohydrates, glucose and other sugars are preferentially taken up 
by the bacterium via the phosphotransferase system (PTS). Glucose and other PTS-
sugars like fructose, mannose and cellobiose are the preferred carbon sources for L. 
monocytogenes when it grows in minimal liquid media. The study of its genome has 
revealed an unusually large number of genes (>40) encoding PTS. Unlike the other low 
G+C Gram-positive bacteria, which have ptsG gene encoding PTS-dependent glucose 
transporter, the genome of L. monocytogenes is incomplete. Despite this deletion, the 
growth of L. monocytogenes is unaffected in minimal media with glucose as the carbon 
source suggesting that this gene is not involved in the glucose uptake[40]. Mertins et al. 
(2007) investigated the possibility of a not PTS-dependent glucose uptake, but the ptsH 
mutant, which did not use the PTS-dependent systems, could not grow in minimal 
medium using glucose as a carbon source. This finding suggests that the PTS transport is 
the mainly one responsible for glucose transport. L. monocytogenes catabolises glucose 
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via the glycolytic and the pentose phosphate pathways, but not via the 
EntnereDoudoroff pathway [40].   
The principal glycolysis genes, i.e. gap, pgk, tpi, pgm and eno, used by L. monocytogenes 
are the same as those found in most low G+C Gram-positive bacteria. These genes are 
down-regulated in minimal medium in favor of an up-regulation of the enzymes 
involved in the pentose phosphate pathway. This up-regulation indicates the need for 
an oxidative decarboxylation of glucose by glucose-6-phosphate and the production of 
CO2 for the biosynthesis of aromatic amino acids, which are not present in the minimal 
medium. Joseph et al. (2006) [44] observed a similar down-regulation of glycolysis genes 
and up-regulation of pentose phosphate pathway when L. monocytogenes grows in host 
cells, perhaps due to a limited availability of PTS sugars. The capability of L. 
monocytogenes to use phosphorylated hexoses (PHs), such as glucose-1-6-phosphate, 
fructose-6-phosphate, as carbon sources have been observed[45]. The bacterium takes 
PHs by the host cytosol and transports them into the cell through the hpt transporter. 
This transporter is under the control of the PrfA virulence regulator, and is highly up-
regulated during the internalization of bacterium onto the host cell [46]. L. 
monocytogenes can use also glycerol as a carbon source (Figure 1.3-1). Glycerol is taken 
up via facilitated transport, phosphorylated by glycerol kinases (encoded by lmo 1034) 
and then oxidized by glycerol-3-phosphate dehydrogenase (encoded by lmo 1538) to 
glyceraldehyde-3-phosphate which is finally metabolized by the glycolytic pathway 
enzymes[40]. The same Authors, instead, excluded amino acids and Acetyl-CoA as 
carbon fonts. The latter is not used by L. monocytogenes due to the lack of the 
glyoxlyate shunt genes and this also rule out the utilization of fatty acids as a carbon 
font. 
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Figure 1.3-1. Simplified view of Listeria metabolic enzymes, transporters, and pathways[47] 
(Fuchs et al., 2012). 
 
L. monocytogenes has a regulatory mechanism, called carbon catabolite repression 
(CCR) which rules prfA virulence regulator and in general the expression of genes 
associated with secondary carbon sources when the primary carbon sources are 
available[48]. This regulatory effect allows L.monocytogenes to grow optimally in the 
presence of various carbon sources using those preferential when they are available. 
Joseph and Goebel (2007) [40] reported that the L. monocytogenes metabolism is 
relieved of CCR control when the bacteria replicate in the host cell cytosol. At the same 
time the Authors observed an up-regulation of genes encoding an uptake mechanism 
for phosphorylated hexoses (hpt), oligopeptides and amino acids (lmo 2251) and 
glycerol (lmo1034, lmo1538). On the basis of these observations it was hypothesized 
that glucose is not a predominant carbon source inside host cells. Moreover, when 
glucose or phosphorylated glucose are not available in the environment, an up-
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regulation of the genes involved in the pentose phosphate cycle and a down-regulation 
of those involved in glycolysis was observed. These results suggest that the pentose 
phosphate cycle is the favorite pathway in the absence of glucose. Concerning nitrogen 
metabolism, glutamine is the preferential nitrogen source for L. monocytogenes. In the 
absence of this amino acid, especially when the bacterium is inside the host cell cytosol, 
it is capable to use alternative fonts, such as such ammonium, which is the favorite 
substitute, arginine and ethanolamine[40, 48]. Inside the L. monocytogenes cell, 
glutamine is converted to glutamic acid by glutamate synthetase (GOGAT) with 2-
oxoglutarate (OG) as additional substrate. On the other hand when ammonium is used 
as an alternative nitrogen source, it is transported in L. monocytogenes by the 
transporter NrgA which is encoded by the ngrAB operon. The transcription of the nrgAB 
promoter is activated during nitrogen-limited growth by the global regulator TnrA. 
Ammonium is then incorporated into glutamine, and further to glutamic acid, as above 
described. This pathway is also observed for Bacillus subtilis. As previously reported, 
also arginine is a potential nitrogen sources. It is transported inside the cell by a specific 
arginine ABC transporter (encoded by arpj) and then degraded into citrulline and 
ammonia by arginine deaminase (encoded by lmo0043-arcA). Citrulline in turn is 
degraded into a further ammonia molecule and ornithine via the enzymes ornithine 
carbamoyl transferase (OCT) and carbamoyl carboxy kinase (CCK) encoded by the L. 
monocytogenes-specific arcBCD operon (lmo 0036 and lmo 0039, respectively). Also 
adenine (to a limited extent) and ethanolamine are two other possible nitrogen sources. 
The latter is generated through the degradation of phosphatidylethanolamine (PEA), 
which is an excellent substrate for PlcB, a listerial phospholipase C encoded by the PrfA-
dependent gene plcB. Ethanolamine is hydrolyzed into ammonia and acetaldehyde by 
the vitamin B12-dependent ethanolamineammonia lyase encoded by the eutBC 
genes[40]. Concerning amino acids biosynthesis, Tsai and Hodgson (2003)[49] observed 
the absence of the genes required for cysteine and methionine biosynthesis. Therefore 
these amino acids are essential for L. monocytogenes which have to absorb them from 
the environment. Moreover, L. monocytogenes lacks also sulphate and nitrate 
reductases, thus there is a dependency for reduced nitrogen and sulphate sources, 
which can be gained from cysteine and methionine. However, L. monocytogenes is 
capable of de novo synthesising branched chain amino acids (BCAA), i.e. valine, 
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isoleucine and leucine, via the conventional pathways. Some studies have shown that L. 
monocytogenes has some requirement for them. In particular, the essential precursors 
of BCAA are pyruvate and threonine (deriving from aspartic acid via oxaloacetate), and 
their availability is directly or indirectly connected with the citrate cycle that is 
interrupted in L. monocytogenes due to the lack of 2-oxoglutarate dehydrogenase, 
which converts alpha-ketoglutarate into succinylCoA. As a result of this incomplete cycle 
, L. monocytogenes is incapable of regenerating oxaloacetate through the Krebs cycle 
from citrate. Therefore, oxaloacetate is produced by the carboxilation of pyruvate by 
pyruvate carboxylase, which is encoded by pycA. This step is fundamental for the 
entrance of Acetyl-CoA into the Krebs cycle and for the synthesis of asparagine, 
threonine, cysteine andmethionine. Because of the interruption of Krebs cycle, 
oxaloacetate is also the precursor of malate and succinate[40]. Buzolyova and Somov 
(1999) observed that pyruvate carboxylase needs CO2 to produce oxaloacetate[50]. 
When glucose is the unique carbon source, the oxidative decarboxylation of glucose-6-
phosphate, which is the first reaction in the pentose-phosphate pathway, seems to be 
necessary as suggested by the high induction of the gene for pyruvate carboxylase in L. 
monocytogenes. Some studies have reported that the major source of nitrogen inside 
the host cell, excluding alanine, asparagine and glutamate which are synthesized de 
novo, is provided by the host cell, as suggested by the up-regulation of the oligopeptide 
transporters[50]. The Authors have also observed a down-regulation of the aminoacyl 
tRNA synthase genes glyS, serS, cysS, alaS, hisS, valS, thrS, ileS, leuS, tyrS, and trpS, as 
suggested availability of the respective amino acids within the cytosol. L. 
monocytogenes cannot synthesize several vitamin and cofactor such as biotin, lipoic 
acid, riboflavin and thiamine which are fundamental for its growth. For instance, lipoic 
acid is an important co-factor of the pyruvate dehydrogenase enzyme (Pdh) complex, 
which is involved in acetyl CoA formation from pyruvate in the aerobic metabolism[51]. 
L. monocytogenes uses two lipoate ligases in order to absorb lipoic acid from the 
environment. 
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1.4 Listeriosis 
The disease caused by bacteria belonging to the genus Listeria is called listeriosis.  
L. monocytogenes is the most pathogenic species for both man and animals. It is a 
prevalent foodborne disease that affects mostly people over 65 years of age, infants, 
pregnant women and immunocompromised such as patients with malignancies or under 
cytotoxic therapy, AIDS patients, diabetics, people with heart valve or kidney or liver 
disease. In particular pregnant women and those suffering from AIDS have a chance 
respectively of about three hundred and twenty times higher than of contracting 
listeriosis compared to a healthy individual (Center for Disease Control and Prevention, 
2009). Listeriosis in pregnant women, which may occur at any time during pregnancy, it 
is generally asymptomatic or begins with a vague symptoms similar to a flu-like 
syndrome accompanied by chills, headache, muscle and joint pain in the period from 2 
to 14 days before spontaneous abortion[23]. The infection is transmitted to the fetus 
through the placenta causing, depending on the time of infection, miscarriage, 
premature birth or neonatal sepsis due to a generalized systemic infection known as 
granulomatosis infantiseptica or neonatal listeriosis. The infection that infants contract 
during childbirth is transmitted by hiring through the airways or the digestive system via 
contaminated amniotic fluid or vaginal secretions and can start early with sepsis and 
respiratory failure and circulatory or (less frequently: 10-15 % of perinatal listeriosis) 
occur episodes of late listeriosis from one to eight weeks postpartum sepsis and 
meningitis[23]. Even less frequently (5% of cases) maternal infection is not transmitted 
to the fetus even in the presence of bacteremia[24]. In young people or adults in 
predisposing conditions listeriosis it occurs mainly in two main forms: 
 
- Non-invasive form whose pathological manifestations occur within hours of ingestion 
(12-24 hours) are not unlike those of other food-borne diseases with phenomena such 
gastrointestinal (diarrhea, vomiting and fever). 
- Invasive form as a result of localized or disseminated infection of the central nervous 
system is manifested by meningitis or meningoencephalitis with headaches, confusion, 
stiff neck, loss of balance or convulsions, and paralysis of the cranial nerves preceded 
from an early stage, three variable to ten days, in which patients have fever, headache, 
vomiting, visual difficulties and general malaise[23]. The average mortality rate for cases 
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of listeriosis reported amounted on average to a percentage between 20 and 30% that 
goes up to 38-45% if referred to cases of listeriosis affecting immunocompromised 
patients or elderly. Despite these figures and the fact that L. monocytogenes is 
ubiquitously widespread and has been isolated in all categories of foods, Listeriosis is a 
rare disease[25] [52].  
As reported in the EFSA report (The Community Summary Report, 2014) regarding the 
European Community, as it relates to a 30% increase compared with 2013. The EU 
notification rate was 0.52 cases per 100,000 population. In 2014, 27 MS reported 2.161 
confirmed human cases of listeriosis (table 1.4-1 and 2). 
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Table 1.4- 1 and 2. Reported human cases of listeriosis and notification rates per 100000 in the 
EU/EEA, by country and year, 2010-2014. 
 
There was a statistically significant increasing trend of listeriosis over 2008-2014. The 
majority of the countries reported increasing notification rates of listeriosis in 2014 and 
six MS had statistically increasing trend. Seventeen MS reported 210 deaths due to 
listeriosis in 2014, which was the highest annual number of deaths reported since 2009. 
The EU case fatality was 15.0% among the 1,401 confirmed cases with known outcome 
(Table 1.4-3). Listeriosis infections were most commonly reported in the elderly 
population with the case fatality peaking at 17.8% in the age group over 65 years old. 
 
Table 1.4-3. Reported hospitalization and case-fatality rates due to zoonoses in confirmed 
human cases in the EU, 2014 
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In 2014, the non-compliance for different RTE food categories was generally at a level 
comparable to previous years, with the level of non-compliance highest in fishery 
products at processing plant (mainly smoked fish). As in previous years and consistent 
with the results of the EU baseline survey on the prevalence of L. monocytogenes in 
certain RTE foods at retail, the proportion of positive samples at retail was highest in fish 
products (mainly smoked fish). 
In 2014, several MS reported information on Listeria in various animal species. Findings 
of Listeria were most often reported in cattle, sheep, goats, pigs and solipeds but 
Listeria was also detected in broilers, cats, dogs, hunted wild boar, foxes, and other wild 
and zoo animals. Listeria is widespread in the environment; therefore, isolation from 
animals is to be expected and increased exposure may lead to clinical disease in animals.  
Listeriosis in animals manifests in different forms depending on the species. In sheep the 
most frequent form is encephalitis, but also abortion and iritis and often death occurs 
within one day of the onset of symptoms. In cattle the neurological form (with the 
appearance of brain microabscesses) presents an evolution less acute and animals 
survive up to two weeks from start of symptoms. Encephalitis can affect animals of any 
age, but prevails in those under three years of age, although it does not appear before 
weaning. In young animals the infection occurs mostly in septicemic form (often fatal) 
with the appearance of necrotic foci in the liver and other abdominal organs. Abortions 
instead are mostly in late gestation. There are other rarer forms of listeriosis such as 
pneumonia, endocarditis, and myocarditis. In cattle we have also been described cases 
of localizations breast with possible etiologic agent elimination through milk even after 
healing has occurred, thus representing a threat to public health. In equines prevails 
meninges-encephalic form, while in pigs and poultry has septicemia is followed by 
symptoms of nervous nature. In humans, the possibility of contracting listeriosis after 
ingestion of contaminated food is closely related to the simultaneous occurrence of 
some predisposing factors related mainly to: 
- Infective dose 
- Features of the pathogenic infecting strain 
- Immunological status of the subject 
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The infectious dose able to determine episodes of listeriosis in an individual can not be 
quantified with accuracy but only estimated. The values shown are generally those 
derived from data for the insolation and the L. monocytogenes amounts determined in 
foods responsible for sporadic episodes or outbreaks of listeriosis. Generally it is 
believed that the infective dose capable of causing disease in humans is between 100-
1,000 CFU/g or ml and 1 x 108 CFU / g or ml. Food products have just microbial loads of 
L. monocytogenes are usually below the indicated doses (between 0.04 and 10 CFU/g): 
are the food intrinsic characteristics (pH, Aw) associated with any heat treatment and 
the conditions of conservation, as well as the elapsed time between the production and 
consumption, which affect positively or negatively on the final microbial food itself. The 
limit of 100 CFU/g as a safety criterion for ready-to-use indicated by the authors of Reg. 
2073/05 takes account of these aspects. In relation to the pathogenic characteristics of 
the infecting strain from studies in vivo and in vitro it has shown that not all strains of L. 
monocytogenes expressing the same degree of virulence [53, 54]. For example at the 
same conditions it was shown that the "relative virulence", obtained by dividing the 
number of dead mice for the number of inoculated mice and expressed in percentage, 
varies between 0 and 100% among different strains all belonging to the species L. 
monocytogenes [55]. Studies directed to understanding these data indicate alterations 
in the gene sequences of some fundamental pathogenicity factors a possible 
explanation for this variability, as well as the presence of new factors of pathogenicity 
whose mechanisms of action are still only partially known[56] [57], including for 
example the internalin J [58]. Assumed to occur predisposing conditions in terms of 
infectious dose and pathogenic strain is crucial because it manifests the disease the 
individual’s health status. Belonging to one of the risk groups affects significantly the 
onset of the disease, but also individuals who do not belong to that defined as 
immunocompetent are exposed to the same risk to a lesser extent. 
In immunocompetent or conditions predisposing ingesting low doses of L. 
monocytogenes may not have any noticeable effect unless the development or 
enhancement of a protective immune response against the microorganism. Conversely, 
in the same subjects an oral exposure to high bacterial loads involves the occurrence of 
the disease in a non-invasive or invasive depending on the virulence of the strain 
involved. In debilitated or immunocompromised individuals who are therefore not able 
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to develop an immune response sufficient to limit bacterial multiplication in the liver, 
the first target organ of L. monocytogenes, also the ingestion of low infectious doses can 
determine the invasive form of the disease. Bacteremia resulting in the massive 
bacterial growth in hepatocytes and release bacterial cells into the bloodstream often 
favors the infection of secondary target organs, such as brain or placenta, or causes 
severe septicemia[23]. 
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1.5 Listeria monocytogenes in Dairy Products: a matter of food safety 
Pasteurized milk and the consumption of soft cheeses have been responsible for 
outbreaks of listeriosis events. L. monocytogenes can be isolated from raw milk tanks 
and dairy products, although with low prevalence[59]. Water samples, used for cheeses 
washing, have also positive results. After collection, raw milk can easily be contaminated 
by environmental sources (soil, faeces, silage) or be excreted from the udder of already 
infected animals. Indeed, it has been observed that cows with mastitis can transfer the 
pathogen in milk with levels of 104-105 CFU/ml. Psychotropic characteristics of L. 
monocytogenes and its ability to grow at refrigeration temperatures, have stimulated 
interest in the study of its behavior in the milk stored at low temperatures. It has been 
shown that in this matrix the inoculum in raw milk of 103 CFU/ml, after 72 hours of 
storage at 5 °C, undergoes increments of 1 log unit, indicating that the milk cooling 
provides limited protection against L. monocytogenes only ensuring a slowdown in 
development time[60]. The pasteurized milk has a low contamination level, but still is a 
substrate adapted to the development during storage. The presence of L. 
monocytogenes in cheeses, in addition to an insufficient thermal consolidation of the 
starting milk, can be attributed to contamination of surfaces, equipment, water waste 
and environments for the transformation. L. monocytogenes is also characterized by a 
particular acid-tolerance, influenced by the temperature of incubation and the 
concentration of salts, but the minimum pH has not yet been well defined. The values of 
pH of the cheeses are such as to not allow the growth of the pathogen, but only the 
survival for different times[59]. L. monocytogenes survives to the cheese processing and 
maturation with a microbial charge almost constant. It increases slightly during the 
manufacture of cheese (cheddar, cottage, italic), focusing in the curd, only to suffer 
decreases during the maturing process, resulting however detectable at the end of the 
maturing The pathogen was isolated from soft and semi-soft cheeses, pressed, fresh, 
semi-hard, from blue cheese, goat, sheep, with contamination levels ranging from 1 to 
100 CFU/g product, even if it is possible reach of 107-108 CFU/g values. Among the 
Italian cheeses, they are particularly involved and streaked with soft cheese, such as 
Gorgonzola and Taleggio.  
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In the soft surface ripening cheeses, such as Camembert, or those blue cheeses like 
gorgonzola and blue cheese, ripening is characterized by the development of non-
acidifying microflora (yeasts, molds, and Micrococcaceae Brevibacteriaceae) that can 
make the most favorable substrate for the growth of pathogen. In Camembert cheese, L. 
monocytogenes has increased by about 1 log in the first 24 hours of production, 
remaining more or less constant after 25 days of ripening at 6°C. Subsequently, a rapid 
increase in the growth occurs, in parallel with the increase of cheese pH. After 56 days 
of curing, the number of cells in the superficial part of the cheese reaches 1x107 CFU/g 
values. Several studies have focused on L. monocytogenes behavior during the 
production of traditional Mozzarella that involves the use of raw milk inoculated with 
levels of 105 CFU/ml and serum-graft use as starter culture. In the first 100 minutes, L. 
monocytogenes is multiplied, then a slight reduction has taken place, indications of the 
presence at the end of the maturation of the curd to the same starting values. After 
spinning, they have showed 2-3 log reduction in the pathogen, which was still present at 
levels of 100 to 1000 CFU/g of finished mozzarella. After 24 hours of conservation in the 
spinning liquid, the pathogen was detectable only after enrichment. The complete 
disappearance of the pathogen occured only after 48 hours of storage. The pathogen 
was detected only after enrichment. 
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1.6 Probiotic LACTIC ACID Bacteria and antimicrobial compounds  
Lactic acid bacteria (LAB) are classiﬁed as Gram-positive, non-spore forming, non-motile, 
and rod-and coccus-shaped organisms that can ferment carbohydrates mainly producing 
lactic acid. Some strains of LAB show attractive therapeutic properties and technological 
applications, such as proteolytic activity; production of polysaccharides; lactose and 
citrate fermentation; capacity for adhesion and colonization in digestive mucosa; high 
resistance to freezing and freeze-drying; production of vitamins; and production of 
antimicrobial compounds [61-63]. The probiotic LAB could be present in the 
spontaneous fermentation of different food, and this group is generally recognized as 
safe[64]. They have been also used as starter cultures, and they have become 
widespread in the manufacture of fermented vegetables and dairy and meat products 
[65, 66]. The fermentation depends on the oxidation of carbohydrates and related 
subproducts to generate end-products. Homofermentative LAB are able to convert 
available energy source (hexoses) almost completely into lactic acid (over 85%) via 
pyruvate to produce energy and to equilibrate the redox balance (Figure 1.6-1), whereas 
heterofermentative LAB degrade hexoses and can lead to the generation of many other 
metabolites (different organic acids, acetate, acetoin, ethanol, carbon dioxide and 
aromatic compounds, such as diacetyl and acetaldehyde) (Figure 1.6-2)[67]. In this way, 
LAB produce volatile substances that contribute to the typical ﬂavor of certain 
fermented products, such as sourdough (determined by the lactate/acetate ratio), keﬁr 
and koumiss (ethanol), butter and buttermilk (diacetyl) and yogurt (acetaldehyde)[68]. 
The preservative effect of these bacteria is due to the production of one or more active 
metabolites, such as organic acids (lactic, acetic, formic, propionic and butyric acids), 
that intensify their action by reducing the pH of the media, and other substances, such 
as ethanol, fatty acids, acetoin, hydrogen peroxide, diacetyl, antifungal compounds 
(propionate, phenyl-lactate, hydroxyphenyl-lactate, cyclic dipeptides and 3-hydroxy 
fatty acids), bacteriocins (nisin, reuterin, reutericyclin, pediocin, lacticin, enterocin and 
others) and bacteriocin-like inhibitory substances (BLIS). However, there are other 
mechanisms that may be involved in the inactivation or inhibition of the growth of other 
related species of bacteria and/or pathogens. As a result, a large number of bacteriocins 
produced by probiotics LAB have been identiﬁed, although their potential application as 
biopreservatives has not been fully developed [69, 70]. 
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Figure 1.6-1 Homolactic fermentation[71] 
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Figure 1.6-2. Heterolactic Fermentation (6-phosphogluconate/phosphoketo¬lase 
pathway). 1 glucokinase; 2 glucose-6-phosphate dehydrogenase; 3 6-phosphogluconate 
dehydrogenase; 4 phosphoketolase; 5 glycer¬aldehyde-3-phosphate dehydrogenase; 6 
pyruvate kinase; 7 lactate dehydrogenase; 8 acetaldehyde dehydrogenase; 9 alcohol 
dehydro¬genase)[71] 
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1.7 Bacteriocin  
Bacteriocins represent a wide group of ribosomally synthesized antimicrobial 
compounds[72, 73]. Bacteriocins are classiﬁed as ribosomal-synthesized peptides, as 
biologically active proteins or protein complexes with antimicrobial activity against 
closely related species, and they are produced by different groups of bacteria. Indeed, 
the ﬁrst bacteriocin production, discovered in 1925, was found in numerous species of 
bacteria [74]. 
In general, these substances are mostly cationic, amphiphilic, membrane-permeabilizing 
peptides. They have been reported to be unstructured in an aqueous solution, but with 
the propensity to form -helical structure when exposed to structure-promoting 
solvents or membrane-mimicking media[75, 76]. The classiﬁcation of bacteriocins is 
based on chemical structure, molecular weight and thermal stability; on that basis four 
classes of bacteriocins (I, II, III and IV) have been deﬁned [77]. Recently, new 
classiﬁcations of bacteriocins have been proposed. Cotter et al. [13] proposed to divide 
the bacteriocins into two different categories: the lantibiotics containing lanthionine 
(Class I) and the non-lanthibiotics (Class II). Class III is reclassiﬁed as bacteriolysins, and 
Class IV has to be withdrawn. The use of bacteriocins in the food industry can help to 
reduce the addition of chemical preservatives as well as the intensity of heat treatment 
or in combination with other conventional treatment as part of hurdle technology. It 
results in more naturally preserved food with better sensorial and nutritional properties. 
Some genera of LAB produce bacteriocins: Lactococcus, Streptococcus, Lactobacillus, 
Pediococcus, Leuconostoc, Enterococcus, Carnobacterium, Aerococcus, Oenococcus, 
Tetragenococcus, Vagococcus and Weisella [61-63, 78, 79]. Bacteriocins have several 
properties that make them suitable for use in food preservation. They are generally 
recognized as safe substances (GRAS); are non-active and non-toxic on eukaryotic cells; 
become inactivated by digestive proteases so have little inﬂuence on the gut microbiota. 
They are generally thermal resistant (maintaining antimicrobial activity after 
pasteurization and sterilization) and have a relatively broad antimicrobial spectrum 
against many foodborne pathogenic and spoilage bacteria. The bactericidal mode of 
action usually acts on the bacterial cytoplasmic membrane, there is no cross-resistance 
to antibiotics, and their genetic determinants are usually plasmid-encoded, facilitating 
genetic manipulation[61].  
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The application of bacteriocins in food preservation can offer many beneﬁts: provide 
extra protection during the abuse of temperature conditions; decrease the risk for 
transmission of foodborne pathogens through the food chain; reduce food losses due to 
spoilage; reduce chemical preservatives; permit the application of less severe heat 
treatment without compromising food safety: better preservation of food nutrients and 
vitamins, as well as sensorial properties of food; permit the marketing of ‘‘novel’’ food 
(less acidic, with a lower salt content and with a higher water content) to satisfy the 
demands of both the industry and consumers[80, 81]. Researchers have proposed the 
possibility of incorporating antimicrobial compounds isolated from LAB and 
biﬁdobacteria directly into food systems and pharmaceutical products. Certain 
strategies have been used to incorporate or use biopreservatives in food: direct use of 
LAB strains with proven antimicrobial activity as starter cultures or starter adjuncts 
(probiotic concept); use of a biopreservative preparation in the form of a previously 
fermented product or use of semi-puriﬁed, puriﬁed or chemically synthesized 
bacteriocins [82]. Food can be supplemented with ex situ produced bacteriocin 
preparations, or with the inoculation of a bacteriocin-producer strain under conditions 
that favor the production of bacteriocins in situ [83, 84]. Several studies have focused on 
ex situ production of bacteriocins as immobilized preparations, in which the partially 
puriﬁed bacteriocin or the concentrated cultured broth is bound to a carrier [78]. This 
carrier acts as a reservoir and diffuser of the concentrated bacteriocin molecules to the 
food ensuring a continuous gradient-dependent supply of bacteriocin. The carrier may 
also protect the bacteriocin from inactivation by interaction with food components and 
enzymatic inactivation. Moreover, the precise localized application of bacteriocin 
molecules on the food surface requires much lower amounts of bacteriocin (compared 
with the application in the whole food volume), decreasing the processing costs. The 
production of bacteriocins in situ offers several advantages when compared to ex situ 
production regarding both legal aspects and costs. The lower cost of biotechnological 
processes may be highly attractive, especially for small economies and developing 
countries, where food safety may be seriously compromised[85]. By the application of 
bacteriocin and/or strains of bacteriocin producer in dairy products, several researchers 
have demonstrated effectiveness against pathogenic bacteria, such as Staphylococcus 
aureus, E. coli, Salmonella spp. and L. monocytogenes, in a type of white cheese and 
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against L. monocytogenes in cheeses, such as Camembert [83, 86]. Among the 
commercial cultures of Lactobacillus spp., the production of an antimicrobial activity 
against pathogenic microorganisms was observed[87, 88]. Those inhibitory activities of 
L. plantarum, L. fermentum and L. acidophilus strains originating from Turkish dairy 
products were due to bacteriocin-like substances, because the neutralization and the 
catalase treatment of supernatants inhibit the antimicrobial activity of organic acids and 
hydrogen peroxide against E. coli and Yersinia enterocolitica and S. aureus[82, 89]. In 
addition, these bacteriocin-like substances are resistant to heat and can be used as 
biopreservatives. Moreover LAB produced bacteriocin in the temperature range of 4–
30°C, and this property could be of interest for applying to refrigerated products[90]. 
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1.8 Regulatory mechanisms of the bacteriocin production 
The production of bacteriocin in food must be understood as a dynamic process during 
which different interactions are always changing, resulting in food preservation[79]. It is 
regulated by quorum-sensing mechanisms. This process means that the cells present in 
the environment produce an extracellular auto-inducer molecule by sensing the 
population density. Once the concentration exceeds a threshold, gene expression is 
induced[91]. In the case of the lantibiotics nisin and subtilin peptides, the structural 
peptide functions act as a pheromone that induces its own production to high levels 
once a cell-density-dependent auto-induction loop is activated [92, 93]. Although Class II 
bacteriocin acts as a pheromone 144, the presence of another induction peptide that 
often shows many of the physicochemical properties of bacteriocins can act at low 
concentrations[94]. The quorum-sensing and inducible bacteriocin production has 
facilitated the development of systems that allow inducible overexpression of desirable 
proteins[13]. According to Cotter et al. [13], bacteriocins cannot be grouped based only 
in their structure, but also on mode of action. Some members of the class I (lantibiotic) 
bacteriocins, such as nisin have showed a dual mode of action. They can bind to lipid II, 
the principal transporter of peptidoglycan subunits from the cytoplasm to the cell wall, 
and therefore prevent correct cell wall synthesis of the cell leading to death. 
Furthermore, they can use lipid II as a docking molecule to initiate a process of 
membrane insertion and pore formation that leads the cell to death. To broaden the use 
of bacteriocinogenic cultures in food biopreservation, it is important to carefully study 
the bacteriocin-producing strains of LAB that are well adapted to the particular food 
environment. It means that the efﬁcacy of bacteriocinogenic cultures as food 
preservatives should be evaluated for each individual food system[95]. 
Bacteriocinogenic strains can be used as starter cultures, as adjunct or co-cultures in 
combination with a starter culture, or as protective cultures (especially in the case of 
non-fermented foods). The culture will grow during food processing and storage and will 
produce enough bacteriocin to inhibit the target pathogenic or spoilage bacteria to 
afford protection. 
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1.9 Nisin 
In 1928, Rogers observed that L. lactis subsp. lactis strains had an inhibitory effect on 
the growth of Lactobacillus bulgaricus [96]. In 1947, this bacteriocin was named nisin, or 
group N inhibitory substance [97]. It is the most characterized bacteriocin produced by 
LAB; it consists of unusual amino acids lanthionine and methyl-lanthionine, and clas-
siﬁed as a class I bacteriocin or lantibiotic[98]. Nisin is Lactococcus lactis prototype 
bacteriocin used as a preservative in the food industry for making dairy products[69, 
99]. 
Nisin is a 34-amino acid antimicrobial peptide, which belongs to the lantibiotic class of 
bacteriocins (Class I). Lantibiotics are small peptides (< 5 kDa) containing the unusual 
amino acids lanthionine (Lan), L-methyllanthionine (MeLan) and a number of 
dehydrated amino acids[100]. Nisin is produced on the ribosome as a prepeptide, which 
contains 57aminoacid with a 23-residue leader region and 34 residue structural region. 
The prepeptide is processed through post-translational modifications that lead the 
dehydration of serine and threonine residues, and cross-linking with cysteine 
residue[101] to result a biologically active peptide. 
The lantibiotics can have multiple mechanisms of action facilitated through the binding 
of lipid II and insertion into bacterial membranes[102]. 
The importance of this bacteriocin is due to a wide spectrum of activity against Gram-
negative and Gram-positive bacteria including L. lactis subsp. lactis and subsp. cremoris. 
L. bulgaricus, S. aureus and L. monocytogenes and prevent the outgrowth of spores of 
many Clostridium and Bacillus spp. [78]. The nisin action occurs through disruption of 
membrane function instigated by formation of pores in the bacterial cell membrane 
followed by leakage of the cellular material[103]. Nisin is present as two major variants 
(A and Z), which differ by a single amino acid substituting histidine at position 27 in nisin 
A and asparagine in nisin Z.  
Below the genomic sequences of Nisin A and Nisin Z that differ by single nucleotide are 
show. 
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AAAACAGCAACTTGTCATTGTAGTATTCACGTAAGC (Lactococcus lactis ATCC 11454-Nisin A) 
AAAACAGCAAATTGTCATTGTAGTATTCACGTAAGC (Lactococcus lactis CRA 26- Nisin Z) 
The structural modiﬁcation has no effect on the antimicrobial activity, but it gives nisin Z 
higher solubility and diffusion characteristics compared with nisin A, which are 
important characteristics for food applications [104]. The discovery of nisin brought to 
the food industry the use of a biopreservative compound produced by LAB. Nowadays, 
nisin is used in a commercial scale as a food preservative, and research on bacteriocins 
produced by LAB, searching for novel bacteriocin-producing strains from dairy, meat and 
vegetable products, and traditional fermented products were carried out [105]. In 
addition, nisin is licensed as a food preservative (E234) and is recognized as safe [64]. 
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1.10 Lactic Acid bacteria in food safety  
The interest on novel biological preservation methods has been increasing over the last 
few decades. It has been mostly supported by researches indicating that antagonistic 
microorganisms and their antimicrobial metabolites may have some potential uses as 
natural preservatives as a way not only to control the growth but also to inactivate 
undesired microorganisms in food. However, one of the worldwide food industry trends 
is the necessity to eliminate the use of synthetic chemicals and additives as 
preservatives. According to the deﬁnition of the Food and Agriculture Organization and 
the World Health Organization (FAO/WHO), probiotics are living microorganisms if, 
when administered in adequate amounts, confer a health beneﬁt on the host *64, 106, 
107]. Biopreservation using lactic acid bacteria (LAB) and/or their antimicrobial 
metabolites represents an alternative for improving food safety. These antimicrobial 
properties of LAB are derived from competition for nutrients and the production of one 
or more antimicrobial active metabolites such as organic acids (principally lactic and 
acetic acid), hydrogen peroxide and also other compounds, such as bacteriocins and 
antifungal peptides. The important contribution of probiotic LAB in food preservation 
has been attracting much attention because of the nutritional qualities of the raw 
material through an extended shelf life of food and their ability to inhibit spoilage and 
foodborne pathogens, which is interesting for the food industry [71]. The deﬁnition of 
biopreservation is the extension of shelf life and enhanced safety of food by the use of 
natural or controlled microbiota and/or antimicrobial compounds[61]. Natural food 
preservation methods that do not affect the health are considered favorable for 
consumers, and they should have a smaller impact on food nutritional and sensory 
properties (as opposed to chemical or physicochemical treatments). At the same time it 
can reduce processing costs and extend the shelf life of the product; it does not require 
advanced technological equipment or skills, and therefore, it can be used by 
undeveloped countries by offering new possibilities to solve emerging issues, such as 
the increase of antibiotic resistance in the food chain, the need to improve animal 
productivity by natural means, or the control of emerging pathogens. Several 
microorganisms, especially (LAB) with antimicrobial properties, have been commonly 
associated with food. The use of LAB strains as probiotic and as bioprotective culture in 
fermented products has also been widely studied.  
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Besides the acid production, some probiotics LAB strains have the ability to produce a 
variety of other antimicrobial compounds, as a natural competitor to other 
microorganisms that share the same niche, such as organic acids, ethanol, hydrogen 
peroxide, several enzymes and bacteriocins. In the case of dairy products, the main 
compound metabolized by those cultures is lactose to lactic acid, which lowers the pH 
value and changes the environment making an unfavorable media for the development 
of some pathogens and spoilage microorganisms [63, 69, 106]. The LAB as competitive 
microbiota has a long history of application in fermented foods. Due to their metabolic 
properties, the LAB is generally employed because of their positive contribution to the 
ﬂavor, texture and nutritional value in food products, besides their natural antimicrobial 
properties that extend the product shelf life. Certain probiotic LAB presents the ability 
to resist acidic conditions and bile salts, and additionally it produces bacteriocins that 
are active against food pathogens and spoilage microorganisms, contributes to a 
probiotic culture that may have potential applications for improving the safety of food 
products [107, 108]. 
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2 EXPERIMENTAL DESIGN  
The following part is divided in three chapters, in which it will be described in details the 
experimental design of the thesis. 
 
 
Figure 2-1. Experimental design of the project 
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3 CHAPTER 1 
3.1 Proteomics and Peptidomics 
The objective of this first part of project was to improve skills in bacterial cultures, and 
microbial proteomics. We applied different methods of bioinformatic analysis to study 
the proteome of cell culture filtrate of Lactococcus lactis growing in competition with 
Listeria monocytogenes to highlight the mechanisms of bacterial competition involved in 
this process.  
In collaboration with Istituto Zooprofilattico della Lombardia e dell’ Emilia Romagna 
(IZSLER), that provided us the culture filtrates used for the analysis, we performed the 
study on the culture filtrates. In particular, in this first part of the project, we have 
developed the extraction of proteins from medium and we performed proteomic 
analysis for the evaluation of proteins secreted by bacteria (proteome of the growth 
media). 
On the other hand, in collaboration with Dr Veronique Monnet (INRA, UMR1319 
MICALIS, Jouy en Josas, France) we performed the evaluation of extracellular peptidome 
analysis of separated Lactococcus lactis and Listeria monocytogenes cultures and of 
these bacteria growing in competition conditions, in order to characterize peptides 
potentially involved in gene regulation. In this part we analyzed peptides directly 
produced by the bacteria in the medium. 
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3.2 Materials and methods 
3.2.1 Bacterial strains and culture condition 
Strains Lactococcus lactis ATCC 11454 and Listeria monocytogenes ATCC 19115, 
obtained from the American type Culture Collection, were provided by IZSLER. They 
were stored at -80°C in BHI broth containing 20% glycerol. 
Both strains were grown in brain heart infusion (BHI) broth at 30°C for 24 hrs. Listeria 
monocytogenes ATCC 19115 preculture (1ml) was inoculted in 100 ml of BHI broth and 
incubated at 37°C for 24h. Preculture of Lactococcus lactis ATCC 11454 (1ml) was 
inoculted in 100 ml of BHI and incubated at 37°C for 24h. Listeria monocytogenes 
preculture (103 ufc/ml) and Lactococcus lactis preculture (108 ucf/ml) were inoculated in 
100 ml of BHI for coculture and incubated at 37°C for 24h. Listeria monocytogenes 
inoculated in BHI after 5 hours of growth of LC ATCC, incubated at 37 ° C. 
3.2.2 Supernatant and lyophilized pellets preparation 
Cultures were centrifuged (10000 g, 20 min, 4°C) and supernatants were recovered. 
Supernatant was filtered using PDVF membrane 0,45µm. The pellet was washed in 5 ml 
of physiological saline, centrifuged at 10000 g for 20 minutes at 4°C and the supernatant 
was discarded, the pellet was resuspended in 2 ml of physiological saline and lyophilize. 
For each experimental group, 100 ml of lyophilized cultures medium taken up in 8 ml of 
H2O. The proteins present in the supernatant were purified and concentrated through 
precipitation with methanol/chloroform/water. The pellet was solubilized in 6M Urea, 
100mMTris pH 7.5 
The experimental groups analyzed are the following: 
1.  3 BHI (brain heart infusion) 
2.  3 BHI with Lactococcus lactis 
3.  3 BHI with Listeria Monocytogenes 
4.  3 BHI and Lactococcus in co-culture with Listeria (LM inoculated in BHI after 5 hours 
of growth of LC ATCC, incubated at 37 ° C). 
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3.2.3 Protein assay 
Protein concentration was determined by Bradford assay. Optical density was measured 
at 595 nm using a spectrophotometer (Gene Quant 100, GE Healthcare) and protein 
concentration was determined against Bovine Serum Albumin (BSA, Thermo Scientific) 
used as standard. A standard curve was prepared with different BSA concentrations 
from 1 to 20 ug. The amount of protein was calculated by interpolation of the 
experimental values with standard proteins to known quantity. 
3.2.4 SDS-Page electrophoresis 
We proceeded to the analysis of protein profile of the samples through one dimensional 
electrophoresis optimized for the separation of molecular weights from 200 to 15 
kilodaltons. 
3.2.5 2D electrophoresis 
The samples of each experimental group were analyzed through 2D electrophoresis. For 
isoelectric focusing (IEF) step, immobilized pH gradient (IPG) polyacrilamide gel strips 
(GE Healthcare, 7 cm, pH 3-10 NL) and Protean IEF Cell (Bio Rad) were utilized. Prior to 
IEF, 200 µg of protein sample was dissolved in a solution containing 7 M Urea, 2 M 
Thiourea, 2% w/v CHAPS, 30 mM DTT, 0.5% w/v Ampholine (pH 3.5-10.0) and 1% w/v 
bromophenol blue. IPG strips were first actively rehydrated in the presence of the 
sample at 50 V and 20°C for 17 h. After the rehydration step, paper wicks soaked in 
water were placed between cathode, anode and gel strip for preventing high voltage to 
cause burning of the strips. The voltage was gradually increased according to the 
following protocol: 100 V (4 h), 250 V (2 h), 4000 V (5 h), 4000 V until the cumulative 
voltage reached 60 kVh. A limitation of current up to 50 µA per gel strip was set. 
Following IEF, each strip was reduced for 15 min in 5 ml of solution containing 6 M Urea, 
2% w/v SDS, 50 mM Tris-HCl buffer, pH 8.8 and 20% v/v Glycerol with 1% w/v DTT 
added, and then alkylated in 5 ml of same solution with 2.5% w/v of IAA. IPG strips were 
then washed shortly in 1x running buffer (250 mM Tris-HCl, pH 8.8, 1920 mM Glycine, 
1% w/v SDS and MilliQ water), loaded onto 12% w/v polyacrylamide resolving gels along 
with the protein ladder and fixed with 0.5% w/v agarose gel. Second dimension was 
carried out in Mini-Protean Tetra system (Bio Rad). In the first step of electrophoresis, 
until the bromophenol blue front line entered the resolving gel, 8 mA per gel for 15 min 
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were applied. In the second step, 16 mA per gel were applied until the bromophenol 
blue front line reached the bottom of the gel. Gels were then removed from the plates, 
washed three times for 5 min in 100 ml of deionised water and left over night to stain in 
100 ml of preheated Coomassie Brilliant Blue G-250 (Sigma-Aldrich)[109].  
3.2.6 Image acquisition and statistical analysis 
Gel images were acquired using a flatbed scanner (ImageScanner III, GE Healthcare, 
Uppsala) with a resolution of 600 dpi. Before scanning, gels were washed for 20 s in 70% 
v/v ethanol and then for 2 min in 100 ml of deionized water. Variations in protein 
expression between each group  were analyzed using the Progenesis SameSpots 
software (Nonlinear Dynamics, UK), Version 4.5. After evaluating the quality of the 
images, the module for 2D gel analysis was used to align the images, subtract 
background, detect, normalize and match spots. At the end, all spots were manually 
reviewed and selected for excision.  
Statistical analysis was performed using the Progenesis Stats module on the log-
normalized volumes for all spots. Stats module performs automatically a One-way 
ANOVA on each spot to evaluate the p value between different groups, p-values under 
0.05 were considered statistically significant.  
3.2.7 MALDI-TOF MS analysis 
Spots were manually excised from 2D gels, destained with washing solution (2,5 M 
ammonium bicarbonate, 50% v/v ACN and MilliQ water) and dehydrated with 100% v/v 
ACN. Each spot was reduced with 10 mM DTT (Amersham Bioscience) for 45 min at 56°C 
and then alkylated for 30 min at 37°C in the dark with 55 mM IAA (Sigma Aldrich). In gel 
digestion with 0,01 µg/µl porcine trypsin (Promega, Madison, WI) solution for 16 h at 
37°C followed. To stop further digestion of peptides by trypsin, 1% v/v TFA in H2O was 
added. Peptides were desalted and concentrated using C18 ZipTip (Millipore), eluted 
with α-cyano-4-hydroxycinnamic acid (CHCA) (3,5 mg/ml CHCA, 50% v/v ACN, 0,1% v/v 
TFA) and spotted on a Ground steel plate (Bruker-Dalonics, Bremen, Germany) 
previously covered with a layer of 10 mg/ml CHCA (10 mg/ml CHCA in 1:1 EtOH:ACN and 
0,001% v/v TFA). Ultraflex III MALDI TOF/TOF spectrometer (Bruker-Daltonics) was used 
to acquire the spectra in positive reflectron mode. External calibration was carried out 
with standard peptide calibration mixture (m/z: 1046.5418, 1296.6848, 1347.7354, 
Page 50 of 114 
1619.8223, 2093.0862, 2465.1983, 3147.4710; Bruker-Daltonics). FlexAnalysis 3.3 
software (Bruker-Daltonics) was applied to analyse mass spectra and select 
moniosotopic peptide masses.  
Internal calibration on known trypsin autolysis peaks (m/z: 842.509 and 2211.104) and 
contaminant ions exclusion of matrix and human keratin peaks was performed and the 
created peak lists were analyzed by MASCOT v.2.4.1. Following parameters were used 
for database searching: fixed and variable modifications were defined as 
carbamidomethylation of cysteins and oxidation on methionins, respectively, up to one 
missed cleavage was set for trypsin and protein mass tolerance was defined as 50 ppm. 
Mascot scores above 60 were considered significant in protein identification assignment 
(p<0,05). Protein identifications were obtained searching against curated databases 
restricted to Lactococcus lactis subsp. lactis and Listeria Monocytogenes. 
In order to confirm the obtained identifications, LIFT mode of the instrument was 
applied to acquire MS/MS spectra with 4–8 x 103 laser shots using the instrument 
calibration file. Precursor ions were manually selected for the fragmentation and the 
precursor mass window was automatically set. Spectra baseline subtraction, smoothing 
(Savitsky-Golay) and centroiding were operated using Flex-Analysis 3.1 software for each 
MS/MS spectra acquired. Following parameters were used for database search: 
maximum one missed cleavage was established, carbamidomethylation of cysteins and 
oxidation of methionine was set among fixed and variable modifications, respectively, 
and the mass tolerance was set at 50 ppm for precursor ions and 0.4 Da for fragments. 
The taxonomy was restricted to Bos taurus. Protein identification confidence interval 
was set to 95% (p<0.05) so, to be considered correctly identified, peptides had to have 
an individual identification score above the identity threshold. 
 
3.2.8 Peptidomic Analysis 
One strain of Lactococcus lactis (ATCC 11454) and one strain of Listeria monocytogens 
(ATCC 19115) have been used in the present study. For the culture of both bacteria we 
used chemically defined medium (MCD) that does not contained peptides in order to 
analyze only peptides produced by bacteria in the medium. 
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We analyzed three different conditions: monoculture of Listeria, monoculture of 
Lactococcus lactis and co-culture of Listeria+ Lactococcus lactis.  
After centrifugation, filtration and concentration, samples were analyzed trought HPLC 
coupled to LTQ orbitrap. LC-MS/MS analysis was performed on the PAPPSO platform 
(INRA, Jouy-en-Josas, France). An Ultimate 3000 LC system (Dionex) was connected to a 
linear ion trap mass spectrometer (LTQ, Thermo Fisher) by a nanoelectrospray interface 
to conduct the separation, ionization and fragmentation of peptides, respectively. 
Peptidomic data were analyzed by X!Tandem Pipeline software.   
3.2.9 Bioinformatics analysis 
The genomic sequence of strains has been analyzed for the presence of short genes at 
the MIGALE plateform (INRA, Jouy-en-Josas, France) using the BactGeneShow program. 
A gene containing from 48 to 183 bases (peptide from 15 to 60 amino acids) is 
considered as a short gene (artificial cut off), genes containing more than 183 bases are 
considered as "normal" genes[110]. Short genes potentially coding for short peptides 
that are potentially involved in quorum-sensing systems. The threshold that has been 
used is mainly based on removal of predictions related to genes shorter than 48 bases. 
Three steps are fundamental for the construction of the database used for the peptides 
identification: 
1. Extraction of the regions corresponding to coding sequences 
2. Reversion of the nucleotidic sequences those are located on the reverse DNA strand 
3. Conversion from nucleotides to amino acids. 
All these steps are done using bio-informatic scripts that are enclosed in the EMBOSS 
package. 
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3.3 Results 
All analysis was made on the biological and technical triplicate. 
3.3.1 Analysis through SDS-PAGE and mass spectrometry 
 
 
Figure 3.3.1-1. One-dimensional electrophoresis of filtered bacterial growth media . BHI (Brain 
Heart infusion growth media); LAC (Lactococcus lactis); LM (Listeria monocytogenes); LM+LAC 
(bacterial co-culture filtrate). The "sets" representing each biological replicate. 1D 
electrophoresis analysis is optimized for the separation of molecular weights from 220 to 15 
kDa. 
In figure 3.3.1-1 the one-dimensional electrophoresis analysis highlighting protein bands 
analysed through mass spectrometry is shown as representative of each experimental 
biological replicate group. The data obtained show the presence of a protein band 
present only in the condition of bacterial competition (BHI + LAB + LM). Arrow 1 and 2 
indicate protein bands that show a different expression between the condition of 
Listeria monocytogenes monoculture (LM) and the condition of bacterial competition 
(LAB+LM). 
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3.3.2 Analysis through two-dimensional electrophoresis and mass 
spectrometry  
Maps of filtered cell of the various experimental groups were performed through two-
dimensional electrophoresis. In figure 3.3.2-1 the two-dimensional maps of the filtered 
cell of three experimental groups are represented. Image analysis performed showed, as 
indicated by the arrow in figure 3.3.2-1, the appearance of a spot representing a protein 
secreted again by one of two bacteria only in conditions of co-culture (panel a). In the 
panel b and c, as indicated by the arrow, spot representing 2942 is not 
present.
 
Figure 3.3.2-1. Maps of the 2DE of filtered bacterial growth media of three experimental groups - 
Filtered cell co-cultures of the two bacteria (Lab+LM,panel a); filtered monoculture of LAB (panel b) and 
filtered cell monoculture of LM (panel C) 
 
The protein derived from the band obtained by one-dimensional gel and from the spot by 
2D gel was analysed by MALDI TOF analysis. The protein expressed only in the condition 
of co-culture was identified as Enolase of Listeria monocytogenes (gi|46908628, NCBI 
database). 
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3.3.3 Peptidomics Analysis 
 
 
Figure3.3.3-1 Growth curves of monoculture (Listeria ATCC 19115, Lactococcus lactis ATCC 
11454) and co-culture (Listeria monocytogenes ATCC 19115-Lactococcus lactis ATCC 11454). 
Culture was stopped at OD600 of 1.0, corresponding to the exponential growth phase. 
 
In Figure 3.3.3-1 growth curves of monoculture and coculture of Listeria monocytogenes 
and Lactococcus lactis with different strains are shown.  
Database searching, performed by X! Tandem Pipeline, allowed the identification of 
peptides that accumulate in the medium during the growth of the strains. About 957 
peptides were identified for the LM ATCC 19115 monoculture, 2350 for Lactococcus 
lactis ATCC 11454 and 1440 for the mixed culture. 957 peptides derive from 115 
proteins for the monoculture of Listeria monocytogenes ATCC 19115; 2350 peptides 
from 110 proteins for the monoculture of Lactococcus lactis ATCC 11454 and 1440 
peptides derive from 115 proteins identified in mixed culture (Figure 3.3.3-2). 
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Figure 3.3.3-2 Representative distribution of proteins identified in Monoculture (Listeria 
monocytogenes ATCC 19115, Lactococcus lactis ATCC 11454) and in co-culture  
(Listeria-Lactococcus). In the red circle, the number of proteins identified only in coculture 
condition. 
Page 56 of 114 
 
Description log(E value) Coverage MW Spectra Specific 
uniques 
Uniques 
ATCC_11454_50S ribosomal protein L2|Cytoplasmic -10,77275658 9 13 5 - 3 
ATCC_11454_F0F1 ATP synthase subunit C|Extracellular, Secreted via 
minor pathways (bacteriocin) (no CS) 
-19,13783073 38 7,3 13 - 4 
ATCC_11454_ (ABC transporter substrate-binding protein  -157,9499359 50 59,9 55 - 32 
ATCC_11454_recombinase A|Cytoplasmic -15,20877838 9 41,3 4 - 4 
ATCC_11454_ ABC transporter substrate-binding protein -620,2020874 89 59,6 317 - 139 
ATCC_11454_peptidyl-prolyl cis-trans isomerase|Membrane, N-
terminally anchored (No CS) 
-4,920818806 10 29,9 2 - 2 
ATCC_11454_gamma-aminobutyrate permease   -22,81734085 10 51,8 6 - 6 
ATCC_11454_oligopeptide ABC trasporter ATP binding 
protein|Cytoplasmic 
-4,221848488 6 38,8 4 - 2 
ATCC_11454_oligopeptide ABC trasporter ATP binding 
protein|Cytoplasmic 
-11,87245464 7 34,8 4 - 4 
ATCC_11454_ amino acid permease -16,05438042 11 49,9 10 - 6 
ATCC_11454_DNA-directed RNA polymerase subunit 
alpha|Cytoplasmi 
-13,19205952 4 34 4 - 3 
ATCC_11454_50S ribosomal protein L30|Cytoplasmic -9,563837051 21 6,1 4 - 2 
ATCC_11454_30S ribosomal protein S5|Cytoplasmic -10,19942093 21 17,5 4 - 4 
ATCC_11454_glycerophosphodiester phosphodiesterase]  -100,8089447 14 76,7 37 - 15 
ATCC_11454_superoxide dismutase|Cytoplasmic -6,912218571 10 23,2 3 - 3 
ATCC_11454_|carbon starvation protein|Membrane, Multi-
transmembrane 
-14,46248341 4 85,1 8 - 4 
ATCC_11454_ beta-lactamase -75,20846558 32 50,3 27 - 18 
ATCC_11454_transport permease|Membrane, Multi-transmembrane -14,755723 10 26 4 - 4 
ATCC_11454_30S ribosomal protein S9|Cytoplasmic -5,706969261 9 13,6 3 - 3 
ATCC_11454_glutamate synthase subunit beta|Cytoplasmic -9,819014549 2 52,2 2 - 2 
ATCC_11454_|glutamate synthase large subunit|Cytoplasmic -23,7961998 3 164,2 7 - 7 
ATCC_11454_branched-chain amino acid 
aminotransferase|Cytoplasmic 
-5,207608223 5 36,8 4 - 2 
ATCC_11454_ D-alanine transfer protein DltD  -102,35923 48 48,6 46 - 23 
ATCC_11454_FtsW1|Membrane, Multi-transmembrane -10,40230465 3 46 3 - 3 
ATCC_11454_pyruvate kinase|Cytoplasmic -21,3377533 6 54,1 7 - 6 
ATCC_11454_ RTX toxin  -35,34415817 11 69,5 10 - 8 
ATCC_11454_carbamoyl phosphate synthase large 
subunit|Cytoplasmic 
-10,40726852 1 117,4 5 - 4 
ATCC_11454_N-acetylmuramidase|Extracellular, secreted -25,14151764 28 23,6 7 - 5 
ATCC_11454_|transporter|Membrane, Multi-transmembrane -36,43174744 18 43,3 14 - 13 
ATCC_11454_penicillin-binding protein 1B|Membrane  -40,01389694 15 86,8 22 - 12 
ATCC_11454_tyrosyl-tRNA synthetase|Cytoplasmic -22,69204903 14 47,1 9 - 6 
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ATCC_11454_oxidoreductase|Cytoplasmic -13,8986578 15 36,5 5 - 5 
ATCC_11454_asparaginyl-tRNA synthetase|Cytoplasmic -12,95002651 7 50,7 5 - 4 
ATCC_11454_peptide-binding protein  -103,0604858 38 65,9 31 - 23 
ATCC_11454_ N-acetylmuramoyl-L-alanine amidase   -51,55121994 3 53,6 23 - 7 
ATCC_11454_fructose-bisphosphate aldolase|Cytoplasmic -17,89045906 5 31,9 7 - 7 
ATCC_11454_|myosin-cross-reactive antigen|Membrane, N-
terminally anchored (No CS) 
-24,38909721 13 67 8 - 7 
ATCC_11454_molecular chaperone DnaK|Cytoplasmic -5,711303711 3 64,8 2 - 2 
ATCC_11454_D-alanyl-D-alanine carboxypeptidase|Membrane, N-
terminally anchored (No CS) 
-4,106792927 14 27,4 2 - 2 
ATCC_11454_amino acid ABC transporter substrate-binding protein  -108,8238373 46 30,5 29 - 19 
ATCC_11454_phosphopentomutase|Cytoplasmic -7,69389677 5 45,7 3 - 3 
ATCC_11454_transcription regulator|Membrane, N-terminally 
anchored (No CS) 
-10,71955872 7 33,6 3 - 3 
ATCC_11454_proline dipeptidase|Cytoplasmic -6,598255157 2 39,8 2 - 2 
ATCC_11454_ valyl-tRNA synthetase -9,61783886 3 100,4 3 - 3 
ATCC_11454_transcription regulator|Cytoplasmic -12,19585991 12 10,8 2 - 2 
ATCC_11454_ Putative uncharacterized protein yedB  -41,91228104 23 36,7 11 - 8 
ATCC_11454_ membrane protein  -25,69314003 10 56,6 12 - 5 
ATCC_11454_cold shock protein E|Cytoplasmic -69,72196198 68 7 19 10 13 
ATCC_11454_hypothetical protein|Membrane, N-terminally anchored 
(No CS) 
-5,045757294 7 28,8 2 - 2 
ATCC_11454_UDP-N-acetylglucosamine 1-
carboxyvinyltransferase|Cytoplasmic 
-3,886056662 2 45,7 2 - 2 
ATCC_11454_ (ABC transporter) -76,96114349 24 85 47 - 19 
ATCC_11454_dTDP-4-keto-6-deoxyglucose-3, 5-
epimerase|Cytoplasmic 
-10,11278629 15 22,2 4 - 4 
ATCC_11454_x-prolyl-dipeptidyl aminopeptidase|Cytoplasmic -11,56288433 3 87,6 3 - 3 
ATCC_11454_arginyl-tRNA synthetase|Cytoplasmic -18,26686668 5 62,8 6 - 5 
ATCC_11454_|amino acid ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-35,35427094 16 30,9 18 - 7 
ATCC_11454_glyceraldehyde 3-phosphate 
dehydrogenase|Cytoplasmic 
-41,43119049 11 25 12 - 10 
ATCC_11454_transporter|Membrane, Multi-transmembrane -11,43475628 7 17,2 3 - 3 
ATCC_11454_fumarate reductase -210,8803406 69 52,7 95 - 56 
ATCC_11454_thiamine biosynthesis lipoprotein|Extracellular -39,8343544 26 39,6 13 - 9 
ATCC_11454_50S ribosomal protein L27|Cytoplasmic -13,32505894 20 10 4 - 4 
ATCC_11454_phosphate ABC transporter substrate-binding 
protein|Extracellular, Lipid anchored 
-15,44869709 9 30,5 9 - 3 
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ATCC_11454_Lasergene_maturation protein|Extracellular, Lipid 
anchored 
-22,03201675 18 33,7 11 - 4 
ATCC_11454_manganese ABC transporter substrate-binding protein  -22,38810349 22 34,9 8 - 6 
ATCC_11454_glycerol-3-phosphate acyltransferase PlsX|Cytoplasmic -7,545155048 6 34,5 2 - 2 
ATCC_11454_ Nisin immunity protein -78,19429779 58 27,7 42 - 23 
ATCC_11454_peptidase -79,39823151 21 74,6 31 - 21 
ATCC_11454_ nisin biosynthesis two-component system, sensor 
histidine kinase NisK  
-13,74126625 7 50,5 4 - 3 
ATCC_11454_ lantibiotic ABC transporter permease  -7,78188467 12 27,5 4 - 3 
ATCC_11454_ Basic membrane protein A -118,1277466 45 36,5 35 - 23 
ATCC_11454_(lysine specific permease -235,8040466 28 51,7 65 - 52 
ATCC_11454_glutamine ABC transporter permease and substrate 
binding protein|Membrane, Multi-transmembrane 
-54,88779449 8 78,2 36 - 14 
ATCC_11454_30S ribosomal protein S20|Cytoplasmic -19,55498695 35 8,3 7 - 5 
ATCC_11454_30S ribosomal protein S10|Cytoplasmic -3,83505249 10 11,7 2 - 2 
ATCC_11454_1-deoxy-D-xylulose-5-phosphate synthase|Cytoplasmic -12,53276253 2 57,9 3 - 3 
ATCC_11454_transglycosylase -52,34898376 13 20,5 28 - 8 
ATCC_11454_penicillin-binding protein|Membrane, N-terminally 
anchored (No CS) 
-23,44273758 8 83,3 5 - 5 
ATCC_11454_616|prolyl-tRNA synthetase|Cytoplasmic -8,44009304 1 69,1 3 - 2 
ATCC_11454_[3749-4285]hypothetical protein|Cytoplasmic -16,72498894 6 20,5 5 - 3 
ATCC_11454_hypothetical protein|Membrane, N-terminally anchored 
(No CS) 
-43,07733536 45 18,7 15 - 11 
ATCC_11454_outer membrane lipoprotein precursor|Membrane, N-
terminally anchored (with CS) 
-15,4644537 18 31,1 7 3 4 
ATCC_11454_outer membrane lipoprotein precursor|Membrane, N-
terminally anchored (No CS) 
-34,79339218 26 31,2 14 6 7 
ATCC_11454_ferrichrome ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-16,28508377 13 34,2 4 - 4 
ATCC_11454_ penicillin-binding protein 2A  -101,8434525 21 74,3 27 - 17 
ATCC_11454_|zinc ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-29,08574486 23 30 16 - 7 
ATCC_11454_hypothetical protein|Cytoplasmic -5,279840946 9 17,7 2 - 2 
ATCC_11454_autolysin|Cell wall associated ( LysM domain) -21,94146729 14 46,5 10 - 5 
ATCC_11454_endo-1,4-beta-xylanase D|Membrane, N-terminally 
anchored (No CS) 
-38,67086029 13 41,6 14 - 5 
ATCC_11454_ permidine/putrescine ABC transporter substrate-
binding protein  
-32,58127594 19 40,5 14 - 7 
ATCC_11454_hypothetical protein|Membrane, Multi-transmembrane -24,66345978 27 10,8 10 - 6 
ATCC_11454_30S ribosomal protein S1|Cytoplasmic -17,9473381 9 44,6 5 - 5 
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ATCC_11454_dipeptidase PepV|Cytoplasmic -16,70692444 5 51,8 10 - 7 
ATCC_11454_ copper transporter  -8,059882164 6 77,4 2 - 2 
ATCC_11454_hypothetical protein|Membrane, Multi-transmembrane -10,87575722 5 26,3 4 - 3 
ATCC_11454_|glutamine synthetase|Cytoplasmic -9,494850159 5 49,6 2 - 2 
ATCC_11454_|glutamate or arginine ABC transporter substrate 
binding protein|Extracellular, Lipid anchored 
-15,30856514 16 28,4 7 - 3 
ATCC_11454_|glyceraldehyde 3-phosphate 
dehydrogenase|Cytoplasmic 
-41,43119049 8 35,9 12 - 10 
ATCC_11454_hypothetical protein|Membrane, N-terminally anchored 
(with CS) 
-30,82732964 25 35,3 10 - 7 
ATCC_11454_glucokinase|Cytoplasmic -6,573000908 7 33,7 4 - 3 
ATCC_11454_deoxynucleoside kinase|Cytoplasmic -15,47118664 11 24,6 4 - 4 
ATCC_11454_exported serine protease|Membrane, N-terminally 
anchored (No CS) 
-21,69059753 9 41,5 8 - 5 
ATCC_11454_|hypothetical protein|Extracellular, Lipid anchored -33,56362152 19 36,6 14 - 10 
ATCC_11454_ Nisin biosynthesis protein NisB  -116,957695 20 103,8 44 - 34 
ATCC_11454_ lantibiotic nisin-A  -273,5541687 43 5,9 716 - 37 
ATCC_11454_|transcription regulator|Cytoplasmic /TMH start AFTER 
60 
-31,89652252 14 52,1 11 - 6 
ATCC_11454_signal peptidase I|Membrane, N-terminally anchored 
(No CS) 
-19,87844086 22 23,5 10 - 3 
ATCC_11454_elongation factor G|Cytoplasmic -8,620876312 4 77,8 3 - 3 
ATCC_11454_hypothetical protein|Membrane, Multi-transmembrane -19,39291573 10 39 13 - 5 
ATCC_11454_D-alanyl-D-alanine carboxypeptidase  -35,75728989 21 46,8 13 - 9 
ATCC_11454_MULTISPECIES: hypothetical protein [Lactobacillales]  -25,91507149 27 20,8 13 - 6 
ATCC_11454_rod shape-determining protein MreC|Membrane, N-
terminally anchored (with CS) 
-45,94273758 27 31,3 14 - 8 
ATCC_11454_ AAA-ATPase, putative  -9,290730476 1 83,9 2 - 2 
ATCC_11454_ mucus-binding protein  -52,85584259 12 30,5 31 - 7 
 
Figure 3.3.3-3 Proteins identified in medium from Lactcococcus lactis monoculture. 
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ATCC_11454_ oligopeptide ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-90,75102234 35 59,9 39 - 21 
ATCC_11454_ recombinase A|Cytoplasmic -9,121133804 8 41,3 3 - 3 
ATCC_11454_ ABC transporter substrate-binding protein  -385,2743835 72 59,6 168 - 86 
ATCC_11454_ amino acid permease  -16,95748329 9 49,9 13 - 6 
ATCC_11454_|DNA-directed RNA polymerase subunit 
alpha|Cytoplasmic 
-13,3391819 4 34 4 - 3 
ATCC_11454_ 50S ribosomal protein L30|Cytoplasmic -9,95039463 21 6,1 3 - 2 
ATCC_11454_ glycerophosphodiester phosphodiesterase  -71,66625977 13 76,7 26 - 12 
ATCC_11454_Lasergene_penicillin-binding protein 2B|Membrane, N-
terminally anchored  
-5,585026741 2 60,2 3 - 2 
ATCC_11454_elongation factor Tu|Cytoplasmic -8,530413628 15 21 3 - 3 
ATCC_11454_Lasergene_ carbon starvation protein|Membrane, 
Multi-transmembrane 
-7,753501415 1 85,1 3 - 2 
ATCC_11454_ beta-lactamase -26,34361649 21 50,3 14 - 9 
ATCC_11454_D-alanine transfer protein|Membrane, N-terminally 
anchored  
-65,02615356 28 48,6 30 - 13 
ATCC_11454_ pyruvate kinase|Cytoplasmic -13,9910593 6 54,1 5 - 4 
ATCC_11454_ RTX toxin  -22,57942963 11 69,5 10 - 7 
ATCC_11454_carbamoyl phosphate synthase large 
subunit|Cytoplasmic 
-6,911863804 1 117,
4 
3 - 2 
ATCC_11454_ transporter|Membrane, Multi-transmembrane -17,53790855 9 43,3 7 - 6 
ATCC_11454_ penicillin-binding protein 1B|Membrane, N-terminally 
anchored  
-33,08220673 13 86,8 15 - 9 
ATCC_11454_|tyrosyl-tRNA synthetase|Cytoplasmic -18,95018005 10 47,1 7 - 5 
ATCC_11454_ asparaginyl-tRNA synthetase|Cytoplasmic -7,494850159 4 50,7 2 - 2 
ATCC_11454_ peptide-binding protein  -63,33303452 28 65,9 26 - 17 
ATCC_11454_ N-acetylmuramoyl-L-alanine amidase  -39,82132721 3 53,6 16 - 7 
ATCC_11454_ fructose-bisphosphate aldolase|Cytoplasmic -3,414539337 4 31,9 2 - 2 
ATCC_11454_ myosin-cross-reactive antigen|Membrane, N-
terminally anchored (No CS) 
-10,87305737 7 67 5 - 4 
ATCC_11454_ molecular chaperone DnaK|Cytoplasmic -5,360015869 3 64,8 3 - 2 
ATCC_11454_ amino acid ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-68,94965363 40 30,5 20 - 13 
ATCC_11454_ Putative uncharacterized protein yedB  -32,14206696 17 36,7 7 - 6 
ATCC_11454_ bifunctional acetaldehyde-CoA/alcohol 
dehydrogenase|Cytoplasmic 
-21,39892387 3 98 9 - 7 
ATCC_11454_|aminopeptidase N|Cytoplasmic -6,583359241 2 95,2 2 - 2 
ATCC_11454_ cold shock protein E|Cytoplasmic -31,81031418 56 7 9 - 6 
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ATCC_11454_ hypothetical protein|Membrane, N-terminally 
anchored (No CS) 
-5,505845547 7 28,8 2 - 2 
ATCC_11454_ UDP-N-acetylglucosamine 1-
carboxyvinyltransferase|Cytoplasmic 
-4,440572262 2 45,7 2 - 2 
ATCC_11454_ hypothetical protein|Membrane, Multi-
transmembrane 
-50,14336395 14 85 40 - 12 
ATCC_11454_ |50S ribosomal protein L28|Cytoplasmic -4,034327984 38 7,1 3 - 2 
ATCC_11454_hypothetical protein|Membrane, N-terminally 
anchored (No CS) 
-38,72576141 28 31,5 11 - 8 
ATCC_11454_ |HU like DNA-binding protein|Cytoplasmic -16,62662697 44 9,6 5 - 3 
ATCC_11454_ hypothetical protein|Cell Wall, LPxTG Cell-wall 
anchored 
-46,71979904 9 160,
9 
18 - 13 
ATCC_11454_amino acid ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-15,04762077 9 30,9 8 - 4 
ATCC_11454_glyceraldehyde 3-phosphate 
dehydrogenase|Cytoplasmic 
-25,88830948 10 25 7 - 7 
ATCC_11454_|transporter|Membrane, Multi-transmembrane -7,563837528 15 17,2 3 - 3 
ATCC_11454_ fumarate reductase flavoprotein subunit|Extracellular, 
Lipid anchored 
-141,0642548 62 52,7 70 37 38 
ATCC_11454_thiamine biosynthesis lipoprotein|Extracellular, Lipid 
anchored 
-30,80196571 27 39,6 11 - 10 
ATCC_11454_ 50S ribosomal protein L27|Cytoplasmic -8,292770386 20 10 3 - 3 
ATCC_11454_ phosphate ABC transporter substrate-binding 
protein|Extracellular, Lipid anchored 
-13,40318298 9 30,5 6 - 3 
ATCC_11454_Nisin immunity protein -69,8260498 41 27,7 28 - 17 
ATCC_11454_ peptidase   -34,15182495 11 74,6 16 - 10 
ATCC_11454_nisin biosynthesis two-component system, sensor 
histidine kinase NisK  
-5,14266777 7 50,5 4 - 2 
ATCC_11454_lantibiotic ABC transporter permease  -6,443697453 6 27,5 2 - 2 
ATCC_11454_ Basic membrane protein A -71,2654953 31 36,5 19 - 14 
ATCC_11454_ lysine specific permease -191,8108368 32 51,7 58 - 47 
ATCC_11454_ glutamine ABC transporter permease and substrate 
binding protein|Membrane, Multi-transmembrane 
-44,40297318 6 78,2 26 - 10 
ATCC_11454_ 30S ribosomal protein S20|Cytoplasmic -11,30629921 16 8,3 5 - 4 
ATCC_11454_ hypothetical protein|Cytoplasmic -2,973058224 3 67,7 2 - 2 
ATCC_11454_phage infection protein|Membrane, Multi-
transmembrane 
-7,585026741 1 99,4 2 - 2 
ATCC_11454_ 1-deoxy-D-xylulose-5-phosphate 
synthase|Cytoplasmic 
-11,50584507 2 57,9 3 - 3 
ATCC_11454_Lasergene_contig254.fasta[4889-6739] prolyl-tRNA 
synthetase|Cytoplasmic 
-8,047692299 1 69,1 3 - 2 
ATCC_11454_Lasergene_ outer membrane lipoprotein -12,86799717 10 31,1 6 1 3 
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precursor|Membrane, N-terminally anchored (with CS) 
ATCC_11454_ outer membrane lipoprotein precursor|Membrane, N-
terminally anchored (No CS) 
-39,87060165 26 31,2 14 5 7 
ATCC_11454_ ferrichrome ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-23,38294029 18 34,2 8 - 6 
ATCC_11454_|penicillin-binding protein 2a|Membrane, N-terminally 
anchored (No CS) 
-41,62255859 13 74,3 10 - 8 
ATCC_11454_zinc ABC transporter substrate binding 
protein|Extracellular, Lipid anchored 
-21,40572739 15 30 11 - 6 
ATCC_11454_autolysin|Cell wall associated ( LysM domain) -23,46354485 14 46,5 9 - 5 
ATCC_11454_endo-1,4-beta-xylanase D|Membrane, N-terminally 
anchored (No CS) 
-28,7718811 12 41,6 7 - 4 
ATCC_11454_dipeptidase PepV|Cytoplasmic -7,699143887 4 51,8 3 - 3 
ATCC_11454_ |glyceraldehyde 3-phosphate 
dehydrogenase|Cytoplasmic 
-25,88830948 7 35,9 7 - 7 
ATCC_11454_ |N-acetylmuramidase|Cell wall associated (LysM 
domain) 
-54,36312103 37 30,1 17 - 14 
ATCC_11454_Lantibiotic nisin-Z  -199,5661316 43 5,9 548 - 26 
ATCC_11454_ transcription regulator|Cytoplasmic /TMH start AFTER 
60 
-9,265760422 8 52,1 3 - 3 
ATCC_11454_ D-alanyl-D-alanine carboxypeptidase|Membrane, N-
terminally anchored (No CS) 
-27,49382019 14 46,8 10 - 6 
ATCC_11454_rod shape-determining protein MreC|Membrane, N-
terminally anchored (with CS) 
-42,15868378 21 31,3 9 - 7 
ATCC_11454_AAA-ATPase, putative  -8,547906876 1 83,9 2 - 2 
ATCC_11454_ (mucus-binding protein  ) -94,56162262 29 39,6 48 - 22 
 
 
Figure 3.3.3-4 Proteins identified of Lactococcus lactis in medium from co-culture with  
Listeria monocytogenes 
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 [gene=lmo2196] [protein=hypothetical protein] 
[protein_id=NP_465720.1]  
-295,9704285 65 62,4 144 - 73 
 [gene=lmo0275] [protein=hypothetical protein] 
[protein_id=NP_463806.1]  
-223,1373444 69 29,9 105 - 52 
 [gene=lmo2156] [protein=hypothetical protein] 
[protein_id=NP_465680.1]  
-83,05193329 80 13 90 - 21 
 [gene=lmo0412] [protein=hypothetical protein] 
[protein_id=NP_463941.1]  
-102,827858 36 31,2 90 - 22 
 [gene=pflB] [protein=pyruvate formate-lyase] 
[protein_id=NP_464931.1]  
-150,5036011 35 83,7 80 - 45 
 [gene=lmo0355] [protein=fumarate reductase subunit A] 
[protein_id=NP_463885.1]  
-105,3512955 53 54,3 65 - 29 
[gene=lmo0135] [protein=peptide ABC transporter substrate-binding 
protein] [protein_id=NP_463668.1]  
-135,5366669 48 58,2 63 - 28 
 [gene=lmo1634] [protein=bifunctional acetaldehyde-CoA/alcohol 
dehydrogenase] [protein_id=NP_465159.1]  
-124,9096298 30 94,5 58 - 36 
 [gene=lmo0049] [protein=hypothetical protein] 
[protein_id=NP_463582.1]  
-50,7807312 83 6,1 56 - 13 
[gene=lmo0927] [protein=hypothetical protein] 
[protein_id=NP_464452.1]  
-84,45317841 20 74,6 51 - 18 
 [gene=lmo0181] [protein=sugar ABC transporter substrate-binding 
protein] [protein_id=NP_463712.1]  
-113,7911835 36 46,5 48 - 29 
 [gene=gap] [protein=glyceraldehyde-3-phosphate dehydrogenase] 
[protein_id=NP_465982.1] 
-71,51019287 19 36,2 41 - 22 
 [gene=pflA] [protein=pyruvate formate-lyase] 
[protein_id=NP_465441.1]  
-90,11711121 24 85,3 39 - 33 
[gene=iap] [protein=invasion associated secreted endopeptidase] 
[protein_id=NP_464110.1]  
-62,30820084 15 50,2 36 - 13 
 [gene=cydA] [protein=cytochrome D ubiquinol oxidase subunit I] 
[protein_id=NP_466240.1]  
-66,47289276 28 52,7 36 - 18 
 [gene=atpE] [protein=ATP synthase F0F1 subunit C] 
[protein_id=NP_466057.1] 
-94,17996216 47 7,1 33 - 13 
[gene=tcsA] [protein=CD4+ T cell-stimulating antigen, lipoprotein] 
[protein_id=NP_464913.1]  
-80,00270844 47 38,3 30 - 20 
[gene=lmo1333] [protein=hypothetical protein] 
[protein_id=NP_464858.1]  
-52,69665146 14 17,8 28 - 8 
 [gene=lmo0847] [protein=glutamine ABC transporter] 
[protein_id=NP_464373.1]  
-37,95451736 3 53,2 24 - 6 
 [gene=lmo0723] [protein=metyl-accepting chemotaxis protein] 
[protein_id=NP_464250.1]  
-40,08582687 13 65,7 24 - 12 
[gene=lmo2637] [protein=hypothetical protein] 
[protein_id=NP_466160.1] 
-40,94929123 39 32,6 21 - 12 
[gene=lmo1585] [protein=peptidase] [protein_id=NP_465110.1]  -50,85908508 27 36,6 20 - 13 
[gene=spl] [protein=peptidoglycan lytic protein P45] 
[protein_id=NP_466028.1]  
-52,13805008 28 42,6 20 - 10 
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 [gene=rpmE2] [protein=50S ribosomal protein L31] 
[protein_id=NP_466071.1]  
-24,67240143 54 9,2 18 - 10 
[gene=flgE] [protein=flagellar hook protein FlgE] 
[protein_id=NP_464224.1]  
-59,86499786 20 42,7 18 - 12 
 [gene=lmo2754] [protein=D-alanyl-D-alanine carboxypeptidase] 
[protein_id=NP_466276.1]  
-31,09364128 4 48 17 - 7 
Lm_EGDe|NC_003210.1_cdsid_NP_463717.1 [gene=lmo0186] 
[protein=hypothetical protein] [protein_id=NP_463717.1]  
-35,23162842 25 44,4 16 - 9 
 [gene=lmo0178] [protein=xylose repressor] 
[protein_id=NP_463709.1]  
-43,02509689 11 44,9 16 - 9 
 [gene=lmo0644] [protein=hypothetical protein] 
[protein_id=NP_464171.1]  
-22,10790443 2 69,1 15 - 2 
 [gene=lmo0625] [protein=hypothetical protein] 
[protein_id=NP_464152.1]  
-25,31043053 12 26,5 15 - 5 
 [gene=lmo1666] [protein=peptidoglycan-linked protein] 
[protein_id=NP_465191.1]  
-42,83107758 6 184,3 15 - 10 
 [gene=atpB] [protein=ATP synthase F0F1 subunit A] 
[protein_id=NP_466058.1]  
-17,47401047 5 26,9 14 - 4 
 [gene=lmo1303] [protein=cell division suppressor] 
[protein_id=NP_464828.1]  
-28,76209641 33 11,8 14 - 5 
 [gene=lmo0415] [protein=endo-1,4-beta-xylanase] 
[protein_id=NP_463944.1]  
-27,24845886 12 52,4 14 - 7 
 [gene=rplS] [protein=50S ribosomal protein L19] 
[protein_id=NP_465312.1] 
-14,73954678 17 13 13 - 3 
 [gene=rplQ] [protein=50S ribosomal protein L17] 
[protein_id=NP_466128.1]  
-26,08486938 19 15,1 13 - 6 
 [gene=rpmA] [protein=50S ribosomal protein L27] 
[protein_id=NP_465065.1]  
-9,909993172 25 10,5 12 - 4 
[gene=lmo1249] [protein=hypothetical protein] 
[protein_id=NP_464774.1]  
-31,84598732 30 9,1 12 - 7 
 [gene=rpsI] [protein=30S ribosomal protein S9] 
[protein_id=NP_466119.1] 
-20,36712456 36 14,3 11 - 6 
 [gene=rplA] [protein=50S ribosomal protein L1] 
[protein_id=NP_463780.1]  
-19,96768951 12 24,4 11 - 6 
 [gene=rpsM] [protein=30S ribosomal protein S13] 
[protein_id=NP_466131.1]  
-19,20896149 25 13,6 10 - 6 
 [gene=lmo1527] [protein=preprotein translocase SecDF] 
[protein_id=NP_465052.1]  
-30,62588882 7 82,5 10 - 8 
 [gene=lmo0152] [protein=peptide ABC transporter substrate-binding 
protein] [protein_id=NP_463685.1]  
-18,30381012 8 61,9 10 - 6 
 [gene=rpsE] [protein=30S ribosomal protein S5] 
[protein_id=NP_466138.1]  
-30,73596001 21 17,4 10 - 7 
 [gene=flaA] [protein=flagellin] [protein_id=NP_464217.1]  -29,05342484 10 30,3 10 - 6 
 [gene=ftsL] [protein=cell division protein FtsL] 
[protein_id=NP_465564.1]  
-12,87863731 28 13,6 9 - 6 
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[gene=fliP] [protein=flagellar biosynthesis protein FliP] 
[protein_id=NP_464203.1]  
-18,53342819 8 28,6 9 - 3 
 [gene=lmo0130] [protein=5'-nucleotidase] [protein_id=NP_463663.1]  -23,37744522 5 82,4 9 - 5 
 [gene=eno] [protein=phosphopyruvate hydratase] 
[protein_id=NP_465978.1]  
-22,45306206 14 46,4 9 - 7 
 [gene=tuf] [protein=elongation factor Tu] [protein_id=NP_466175.1]  -24,21827507 13 43,2 9 - 6 
 [gene=lmo2518] [protein=LytR family transcriptional regulator] 
[protein_id=NP_466041.1]  
-21,2093277 12 39 8 - 5 
 [gene=fliF] [protein=flagellar MS-ring protein FliF] 
[protein_id=NP_464240.1]  
-25,99409485 8 59,9 8 - 4 
 [gene=lmo1438] [protein=penicillin-binding protein] 
[protein_id=NP_464963.1] 
-19,81234169 10 79,8 8 - 6 
 [gene=lmo0217] [protein=DivIC protein] [protein_id=NP_463748.1]  -14,54817677 13 14,9 8 - 4 
 [gene=lmo1318] [protein=hypothetical protein] 
[protein_id=NP_464843.1]  
-20,40206718 7 46,6 8 - 7 
 [gene=murC] [protein=UDP-N-acetylmuramate--L-alanine ligase] 
[protein_id=NP_465130.1]  
-20,69671059 10 49,9 7 - 6 
 [gene=lmo1216] [protein=N-acetylmuramoyl-L-alanine amidase] 
[protein_id=NP_464741.1]  
-12,40818787 8 36,2 7 - 5 
 [gene=rpsH] [protein=30S ribosomal protein S8] 
[protein_id=NP_466141.1] 
-20,84308815 21 14,6 7 - 4 
[gene=dltD] [protein=DltD protein for D-alanine esterification of 
lipoteichoic acid and wall teichoic acid] [protein_id=NP_464496.1]  
-22,93544769 12 48,4 7 - 4 
 [gene=lmo1250] [protein=antibiotic resistance protein] 
[protein_id=NP_464775.1]  
-22,78182411 13 44,1 6 - 6 
Lm_EGDe|NC_003210.1_cdsid_NP_463711.1 [gene=lmo0180] 
[protein=sugar ABC transporter permease] [protein_id=NP_463711.1] 
[location=180052..180900] 
-27,79893494 11 31,5 6 - 6 
 [gene=murA] [protein=UDP-N-acetylglucosamine 1-
carboxyvinyltransferase] [protein_id=NP_466049.1] 
-18,48212242 12 45,9 6 - 5 
Lm_EGDe|NC_003210.1_cdsid_NP_465743.1 [gene=lmo2219] 
[protein=foldase] [protein_id=NP_465743.1] 
[location=2306833..2307714] 
-19,46470642 13 32,6 6 - 4 
Lm_EGDe|NC_003210.1_cdsid_NP_463581.1 [gene=lmo0048] 
[protein=sensor histidine kinase AgrB] [protein_id=NP_463581.1] 
[location=51775..52389] 
-9,187602043 5 23,3 6 - 3 
 [gene=cysK] [protein=cysteine synthase] [protein_id=NP_463754.1] -19,67457771 9 32,1 6 - 4 
 [gene=lmo2638] [protein=NADH dehydrogenase] 
[protein_id=NP_466161.1]  
-15,77337646 10 70,3 6 - 6 
 [gene=hly] [protein=listeriolysin O precursor] 
[protein_id=NP_463733.1]  
-5,825649261 6 58,6 6 - 2 
 [gene=lmo0441] [protein=D-alanyl-D-alanine carboxypeptidase] 
[protein_id=NP_463970.1]  
-25,44439316 9 74,5 6 - 5 
 [gene=lmo2229] [protein=penicillin-binding protein] 
[protein_id=NP_465753.1] 
-14,31568813 9 77,7 6 - 4 
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[gene=lmo0098] [protein=PTS mannose transporter subunit IID] 
[protein_id=NP_463631.1]  
-9,323287964 13 33,3 5 - 4 
 [gene=lmo0319] [protein=phospho-beta-glucosidase] 
[protein_id=NP_463849.1]  
-12,50440025 4 53,5 5 - 3 
 [gene=lmo1240] [protein=hypothetical protein] 
[protein_id=NP_464765.1] 
-11,48085499 9 19,7 5 - 4 
 [gene=rplP] [protein=50S ribosomal protein L16] 
[protein_id=NP_466148.1]  
-6,537003517 7 16,1 4 - 2 
 [gene=fbaA] [protein=fructose-1,6-bisphosphate aldolase] 
[protein_id=NP_466079.1] 
-8,38111496 7 30 4 - 3 
 [gene=rpmB] [protein=50S ribosomal protein L28] 
[protein_id=NP_465341.1]  
-4,939302444 17 6,9 4 - 2 
[gene=glnA] [protein=glutamine synthetase] 
[protein_id=NP_464824.1]  
-13,95155811 4 50,3 4 - 3 
 [gene=pbpA] [protein=penicillin-binding protein 2A] 
[protein_id=NP_465416.1] 
-12,78728008 5 90,7 4 - 4 
 [gene=dltA] [protein=D-alanine--poly(phosphoribitol) ligase subunit 
1] [protein_id=NP_464499.1] 
-9,501207352 5 58 4 - 4 
 [gene=lmo2192] [protein=peptide ABC transporter ATP-binding 
protein] [protein_id=NP_465716.1]  
-15,23062229 7 36,5 4 - 2 
 [gene=lmo0724] [protein=hypothetical protein] 
[protein_id=NP_464251.1] 
-14,99782372 7 26,7 4 - 4 
 [gene=lmo2504] [protein=cell wall-binding protein] 
[protein_id=NP_466027.1] 
-12,13197041 10 46,9 4 - 4 
 [gene=lmo0132] [protein=inosine 5-monophosphate dehydrogenase] 
[protein_id=NP_463665.1]  
-9,717785835 4 54,9 4 - 3 
 [gene=lmo2362] [protein=amino acid antiporter] 
[protein_id=NP_465885.1] 
-13,57740974 4 55 4 - 3 
 [gene=lmo1068] [protein=hypothetical protein] 
[protein_id=NP_464593.1]  
-17,40723038 5 30,7 4 - 4 
 [gene=lmo0462] [protein=hypothetical protein] 
[protein_id=NP_463991.1]  
-6,977571487 8 16,8 4 - 2 
 [gene=lmo0560] [protein=glutamate dehydrogenase] 
[protein_id=NP_464088.1] [location=complement(598968..600344)] 
-15,11139393 3 49,1 4 - 4 
 [gene=lmo0778] [protein=hypothetical protein] 
[protein_id=NP_464305.1]  
-10,13140297 24 13,5 4 - 3 
 [gene=rpsS] [protein=30S ribosomal protein S19] 
[protein_id=NP_466151.1]  
-6,799423218 13 10,4 3 - 2 
 [gene=rpsK] [protein=30S ribosomal protein S11] 
[protein_id=NP_466130.1]  
-9,243211746 19 13,7 3 - 3 
 [gene=rpoA] [protein=DNA-directed RNA polymerase subunit alpha] 
[protein_id=NP_466129.1]  
-11,32975483 4 34,8 3 - 2 
 [gene=lmo1511] [protein=hypothetical protein] 
[protein_id=NP_465036.1]  
-5,432526588 9 26,7 3 - 3 
 [gene=plcA] [protein=phosphatidylinositol-specific phospholipase c] 
[protein_id=NP_463732.1]  
-14,35971737 8 36,2 3 - 3 
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 [gene=guaB] [protein=inosine-monophosphate dehydrogenase] 
[protein_id=NP_466280.1]  
-8,721868515 2 52,4 3 - 3 
 [gene=pnpA] [protein=polynucleotide phosphorylase] 
[protein_id=NP_464856.1]  
-5,70005703 2 79,4 3 - 3 
 [gene=lmo0727] [protein=glucosamine--fructose-6-phosphate 
aminotransferase] [protein_id=NP_464254.1]  
-10,67985439 4 65,6 3 - 3 
 [gene=lmo2360] [protein=transmembrane protein] 
[protein_id=NP_465883.1]  
-6,301934242 3 97 3 - 3 
 [gene=rplO] [protein=50S ribosomal protein L15] 
[protein_id=NP_466136.1] 
-9,649751663 7 15,7 3 - 2 
 [gene=fus] [protein=elongation factor G] [protein_id=NP_466176.1]  -10,64550781 1 76,7 3 - 2 
 [gene=lysS] [protein=lysyl-tRNA synthetase] 
[protein_id=NP_463759.1]  
-6,953520775 6 57,3 3 - 3 
 [gene=lmo1067] [protein=GTP-binding elongation factor] 
[protein_id=NP_464592.1]  
-10,44733143 2 68,6 3 - 3 
 [gene=fliQ] [protein=flagellar biosynthesis protein FliQ] 
[protein_id=NP_464204.1]  
-7,398374557 13 10,1 2 - 2 
 [gene=rplF] [protein=50S ribosomal protein L6] 
[protein_id=NP_466140.1]  
-5,909389496 12 19,3 2 - 2 
 [gene=rplN] [protein=50S ribosomal protein L14] 
[protein_id=NP_466145.1]  
-7,568636417 11 13,1 2 - 2 
 [gene=atpC] [protein=ATP synthase F0F1 subunit epsilon] 
[protein_id=NP_466051.1]  
-5,806875229 9 14,6 2 - 2 
 [gene=gltX] [protein=glutamyl-tRNA synthetase] 
[protein_id=NP_463768.1]  
-5,41702795 2 55,9 2 - 2 
 [gene=rplV] [protein=50S ribosomal protein L22] 
[protein_id=NP_466150.1] 
-2,776763678 16 12,8 2 - 2 
 [gene=serS] [protein=seryl-tRNA synthetase] 
[protein_id=NP_466269.1]  
-4,113509178 2 49 2 - 2 
 [gene=rpmI] [protein=50S ribosomal protein L35] 
[protein_id=NP_465309.1]  
-7,142667294 17 7,6 2 - 2 
 [gene=lmo1499] [protein=hypothetical protein] 
[protein_id=NP_465024.1]  
-5,690370083 5 40 2 - 2 
 [gene=lmo0516] [protein=encapsulation protein CapA] 
[protein_id=NP_464044.1]  
-19,31875801 3 53,2 2 - 2 
 [gene=asnC] [protein=asparaginyl-tRNA synthetase] 
[protein_id=NP_465420.1]  
-2,919373512 2 48,9 2 - 2 
 [gene=lmo1384] [protein=hypothetical protein] 
[protein_id=NP_464909.1]  
-5,905878544 3 36,3 2 - 2 
 [gene=pbpB] [protein=penicillin-binding protein 2B] 
[protein_id=NP_465563.1]  
-5,267606258 1 81,7 2 - 2 
Figure 3.3.3-5 Proteins identified in medium from Listeria monocytogenes monoculture 
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 [gene=lmo0355] [protein=fumarate reductase subunit A] 
[protein_id=NP_463885.1] 
-20,3242588 14 54,3 12 4 5 
 [gene=iap] [protein=invasion associated secreted 
endopeptidase] [protein_id=NP_464110.1]  
-4,973058224 3 50,2 2 - 2 
 [gene=lmo1067] [protein=GTP-binding elongation factor] 
[protein_id=NP_464592.1]  
-2,973058224 3 68,6 2 - 2 
 [gene=lmo2156] [protein=hypothetical protein] 
[protein_id=NP_465680.1]  
-18,921978 42 13 15 - 3 
 [gene=lmo2196] [protein=hypothetical protein] 
[protein_id=NP_465720.1]  
-9,789146423 8 62,4 3 - 3 
 [gene=rpoA] [protein=DNA-directed RNA polymerase 
subunit alpha] [protein_id=NP_466129.1]  
-13,3391819 4 34,8 4 - 3 
 [gene=rpsH] [protein=30S ribosomal protein S8] 
[protein_id=NP_466141.1]  
-13,86889458 27 14,6 6 3 4 
 
Figure 3.3.3-6 Proteins identified of Listeria monocytogenes in medium from co-culture with  
Lactococcus lactis 
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3.4 Discussion 
The most significant result obtained through the proteomics analysis (one-dimensional 
and two-dimensional electrophoresis) of filtered cell is the expression of enolase of L. 
monocytogenes in the condition of co-culture. Enolase increases by at least 30 percent 
during the co-culture. The enolase is an intermediate glycolytic enzyme, particularly it 
converts 2-phosphoglycerate in phosphoenolpyruvate. Regarding its role during the co-
culture, interesting information underline how the protein secreted into the co-culture 
medium could serve as a signal extracellular. Infact it is known that cell membrane 
proteins can act as signals for uptake of nutrients in the medium. Furthermore, enolase 
belongs to a group “moonlight proteins” which are proteins, normally cytosolic, 
secreted on the wall under certain conditions (mainly to increase the virulence or 
improve the adhesion to a host) and released subsequently in the medium.  
A moonlighting protein is a single protein that has multiple functions that are not due to 
gene fusions, multiple RNA splice variants or multiple proteolytic fragments. 
Moonlighting proteins do not include families of homologous proteins if the different 
functions are performed by different proteins in the protein family. They also do not 
include proteins that have multiple cellular roles but use the same biochemical function 
in each role. A single protein with multiple functions might seem surprising, but there 
are actually more than 100 examples of proteins that 'moonlight'.  
Moonlighting proteins are highly conserved cytoplasmic proteins, present on the 
bacterial surface that can have multiple functions depending on the type of cell in which 
they are expressed. A large number of works have shown that these proteins, which lack 
of transposed signal sequences to the cell surface and anchoring to the membrane 
mechanisms, are located on the surface of microbial pathogens[111] and are mostly 
involved in metabolic pathways and mechanisms in response to cellular stress. Among 
the different bacterial Moonlighting proteins now identified, it is increasingly clear that 
most play an important role in bacterial virulence[112]. Moreover, in some pathogens 
which cause caries, enolase is a molecular target of fluoride ions[113]. That is could 
suggest to monitor the fluoride ions concentration in processing facilities. 
Considering the peptidomic analysis, a very important result obtained is the 
identification of the protein Elongation factor Tu of Lactococcus lactis which increases in 
condition of competition. Elongation factor Tu also belongs to the group of moonlighting 
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proteins, in fact these proteins was recently identified as an actor in adhesion to 
epithelial cells at the surface of Lactobacillus johnsonii. Another interesting result, 
obtained from peptidomic analysis, is related to the identification of Nisin Z. In fact, 
peptides derived fron Nisin Z of Lactococcus lactis were detected in condition of 
competition. On the contrary, peptides derived from Nisin A of Lactococcus lactis were 
detected in Lactococcus lactis monoculture. So, in this manner, Lac in competition 
swiches from Nisin A to Nisin Z production. It is a very interesting result because there is 
no evidence in the literature that describes this change of Nisin production. Infact, in 
general each strain of LAB owns genetic information related only one protein variant 
Nisin so usually each strain is capable to produce one variant of Nisin active against a 
wide range of Gram positive bacteria[31].  
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4 CHAPTER 2 
4.1 Untargeted and targeted proteomics analysis: validation in milk 
A strain of Lactococcus lactis subsp lactis ATCC 11454 has been used in this work to 
study antimicrobial activity against Listeria monocytogenes through the study of each 
secretome in microbial competition. Listeria monocytogenes strain plays an important 
role in the field of food Safety because continues to be a relevant pathogen in dairy 
products, as several recent listeriosis outbreaks were linked to cheeses [114, 115]  
In order to highlight these mechanisms of microbial competition, the secretome of these 
microrganisms has been studied through a proteomic approach of the secretome. The 
present work focused on a first untargeted proteomics analysis in vitro, followed by 
validation directly in a system resuming cheese. 
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4.2 Materials and methods 
Strain of Lactococcus lactis ATCC 11454 and strain of Listeria monocytogens (ATCC 
19115), were cultivated in appropriate medium cultures (BHI), alone and also in 
competition. Filtrated cultures (SECRETOME) were lyophilized and resuspended for 
proteomics analysis. Shotgun analysis on each secretome was performed on nano UPLC-
MS system (Waters Corp., Manchester, UK). 
4.2.1 Bacterial strains and culture condition 
Strains Lactococcus lactis ATCC 11454 and Listeria monocytogenes ATCC 19115, 
obtained from the American type Culture Collection, were provided by IZSLER. They 
were stored at -80°C in BHI broth containing 20% glycerol. 
Both strains were grown in brain heart infusion (BHI) broth at 30°C for 24 hrs. 1 ml of 
Listeria monocytogenes ATCC 19115 preculture (1ml) was inoculted in 100 ml of BHI 
broth and incubated at 37°C for 24h. 1 ml of preculture Preculture of Lactococcus lactis 
ATCC 11454 (1ml) was inoculted in 100 ml of BHI and incubated at 37°C for 24h. 0.5 ml 
of Listeria monocytogenes preculture (103 ufc/ml) and 0.5 ml of Lactococcus lactis 
preculture (108 ucf/ml) were inoculated in 100 ml of BHI for coculture and incubated at 
37°C for 24h. Listeria monocytogenes inoculated in BHI after 5 hours of growth of LC 
ATCC, incubated at 37°C.  
4.2.2 Supernatant and lyophilized pellets preparation 
Cultures were centrifuged (10000 g, 20 min, 4°C) and supernatants were recovered. 
Supernatant was filtered using PDVF membrane 0.45µm. The pellet was washed in 5 ml 
of physiological saline, centrifuged at 10000 g for 20 minutes at 4°C and the supernatant 
was discarded, the pellet was resuspended in 2 ml of physiological saline and 
lyophilized. For each experimental group, 100 ml of lyophilized cultures medium taken 
up in 8 ml of H2O. The proteins present in the supernatant were purified and 
concentrated through precipitation with methanol/chloroform/water. The pellet was 
solubilized in 6 M Urea, 100mMTris pH 7.5 
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The experimental groups analyzed are the following: 
1.  3 BHI (brain heart infusion) 
2.  3 BHI with Lactococcus lactis 
3.  3 BHI with Listeria Monocytogenes 
4.  3 BHI and Lactococcus in co-culture with Listeria (LM inoculated in BHI after 5 hours 
of growth of LC ATCC, incubated at 37 ° C). 
4.2.3 Protein assay 
Protein concentration was determined by Bradford assay. Optical density was measured 
at 595 nm using a spectrophotometer (Gene Quant 100, GE Healthcare) and protein 
concentration was determined against Bovine Serum Albumin (BSA, Thermo Scientific) 
used as standard. A standard curve was prepared with different BSA concentrations 
from 1 to 20 ug. The proteins were quantified with Spectophotometer using the method 
of Bradford with reading of the samples in triplicate at 595nm. The amount of protein 
was calculated by interpolation of the experimental values with standard proteins to 
known quantity. 
 
4.2.4 Protein digestion 
Reduction and alkylation of proteins were obtained by adding 100 mM DTT (1 h at 37°C) 
and 200 mM iodoacetamide (1 h at RT). Protein samples were digested with 1:20 (w/w) 
sequence grade trypsin (Promega, Madison, WI, USA) at 37°C overnight. Reactions were 
stopped by adding 0.1% (v/v) TFA. 
 
4.2.5 Chromatography and mass spectrometry 
0.6 µg of digested proteins were loaded on nanoACQUITY UPLC System (Waters Corp., 
Milford, MA) coupled to a Q-Tof Premier mass spectrometer (Waters Corp., Manchester, 
UK). Saccharomyces cerevisiae Enolase (ScEnolase) digestion was added to samples as 
an internal standard. Tryptic peptides were trapped and desalted onto a Symmetry C18 
5 µm, 180 µm x 20 mm precolumn (Waters Corp.) and subsequently separated using a 
NanoEase BEH C18 1.7 µm, 75 µm x 25 cm nanoscale LC column (Waters Corp.) 
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operating at 35°C. Peptide separation was obtained by a gradient of 3–40% B over 150 
min at a flow rate of 250 nL min-1, followed by a gradient of 40–90% B over 5 min and a 
15 min rinse with 90% B (phase A: water with 0.1% formic acid; phase B: 0.1% formic 
acid in acetonitrile). The Q-Tof Premier mass spectrometer operated in ‘‘Expression 
Mode’’ switching between low (4 eV) and high (15–40 eV) collision energies with a scan 
time of 0.8 s over 50–1990 m/z mass range.  
All analysis was made on the biological and technical triplicate. 
 
4.2.6 Database search 
LC-MS/MS data were processed using ProteinLynx Global-Server (version 3.0.2 PLGS, 
Waters). Protein identifications were obtained with the embedded ion accounting 
algorithm of PLGS software searching against Listeria or Lactococcus or Listeria 
monocytogenes + Lactococcus lactis database (UniprotKB/Swiss-Prot Protein 
Knowledgebase) to which the sequence of ScEnolase (P00924) was appended. 
Parameters for the database search were: automatic tolerance for precursor ions, 
automatic tolerance for product ions, minimum 3 fragment ions matched per peptide, 
minimum 7 fragment ions matched per protein, minimum 2 peptide matched per 
protein, 1 missed cleavage, carbamydomethylation of cysteines and oxidation of 
methionines as fixed and variable modifications. The false positive rate (FPR) of the 
identification algorithm was set under 1%. 
4.2.7 Protein expression profiling 
Quantitative analysis was performed by the PLGS dedicated tool adding to each sample 
as internal standard digestion of Enolase from Saccharomyces cerevisiae (100 fmol) 
according to Silva JC et al[28]. Identified proteins were normalized against P00924 entry 
(ScEnolase) while the most reproducible peptides for retention time and intensity 
deriving from ScEnolase digestion were used to normalize the EMRTs table. The list of 
normalized proteins was screened according to the following criteria: protein identified 
in at least 2 out of 3 runs of the same sample; proteins with a 0 < P > 0.05 or 0.95 < P > 
1, and proteins with a ratio of expression level +/- 0.30 on a natural log scale. 
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4.2.8 Validation  
The experimental conditions are exactly the same used in culture media experiments: 
Listeria monocytogenes and Lactococcus lactis (ATCC 11454) as monocultures and both 
in coculture growing in the fluid milk. 
In order to better investigate the milk protein profile, all samples were depleted from 
caseins as described in [116] ,depleted samples (milk, milk with Listeria monocytogenes, 
Lactococcus lactis with milk, milk with Listeria monocytogenes and Lactococcus lactis) 
were subjected to a proteomic analysis. In particular, the "label free shotgun analysis” 
was conducted by nano UPLC-MS system (Waters), in which 0.6 µg of each sample were 
separated by chromatography coupled to mass spectrometry. Each analysis was 
performed in triplicate biological and technical, processed and analyzed using the 
software PLGS (version 3.0.2, Waters). 
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4.3 Results and Discussion 
In this work the strain of Lactococcus lactis ATCC 11454 has been used to study its 
antimicrobial activity against Listeria monocytogenes through the study of each 
secretome in microbial competition. L. monocytogenes strain plays an important role in 
the field of food Safety because L. monocytogenes continues to be a relevant pathogen 
in dairy products. In order to highlight these mechanisms of microbial competition, the 
secretome of these microorganisms has been studied through a proteomic approach of 
the secretome. The present work focused on an untargeted label free shotgun analysis 
in vitro followed by validation in in a system resuming cheese-making (milk). 
4.3.1 Expression analysis by nLC-MSe 
In table 4.3.1_1 the quantitative analysis of differentially expressed proteins of Listeria 
monocytogenes in BHI monoculture (A) and in coculture (B) with Lactococcus lactis ATCC 
11454, identified by Label-free nUPLC-MS/MS, is shown. 
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Accessiona Description PLGS 
Score 
Amount 
(fmol) 
St dev 
C1KVG6 Aspartate tRNA ligase OS 
Listeria monocytogenes 
serotype 4b strain CLIP80459 
GN aspS PE 3 SV 1 
44.52 
 
7.07 
 
0.01 
C1KY94 Enolase OS Listeria 
monocytogenes serotype 4b 
strain CLIP80459 GN eno PE 3 
SV 1 
147.86 
 
69.01 
 
0.15 
 
P21171 
 
Probable endopeptidase p60 
OS Listeria monocytogenes 
serovar 1 2a strain ATCC BAA 
679 EGD e GN i 
72.54 
 
254.40 
 
0.57 
 
Q71WB8 
 
Elongation factor G Listeria 
monocytogenes serotype 4b 
(strain F2365) 
68.74 
 
n.q 
 
n.q 
 
Q71XG7 
 
Tryptophan--tRNA ligase 
Listeria monocytogenes 
serotype 4b strain F2365 
62.83 n.q n.q 
Q720K2 Uracil DNA glycosylase 2 OS 
Listeria monocytogenes 
serotype 4b strain F2365 GN 
ung2 PE 3 SV 1 
63.53 26.19 0.34 
Q8Y9X7 Uracil DNA glycosylase 1 OS 
Listeria monocytogenes serovar 
1 2a strain ATCC BAA 679 EGD 
e GN ung 
99.33 11.56 0.18 
Q8YAA3 50S ribosomal protein L7 L12 
OS Listeria monocytogenes 
serovar 1 2a strain ATCC BAA 
679 EGD e GN 
1731.26 326.21 4.76 
 
Table A 
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Accessiona Description PLGS 
Score 
Amount 
(fmol) 
St dev 
B8DHE7 Septation ring formation 
regulator EzrA OS Listeria 
monocytogenes serotype 4a 
strain HCC23 GN ezrA 
75.36 10.88 
 
0.09 
C1KY63 Glycine cleavage system H 
protein OS Listeria 
monocytogenes serotype 4b 
strain CLIP80459 GN gcvH P 
 
52.26 97.50 0.05 
 
C1KY94 Enolase OS Listeria 
monocytogenes serotype 4b 
strain CLIP80459 GN eno PE 3 
SV 1 
375.00 177.94 0.65 
 
C1KYI0 
 
50S ribosomal protein L11 OS 
Listeria monocytogenes 
serotype 4b strain CLIP80459 
GN rplK PE 3 SV 1 
1051.00 125.68 0.53 
C1KYI3 50S ribosomal protein L7 L12 OS 
Listeria monocytogenes 
serotype 4b strain CLIP80459 
GN rplL PE 3 S 
2020.00 406.79 0.04 
C1L2V9 DNA mismatch repair protein 
MutS OS Listeria 
monocytogenes serotype 4b 
strain CLIP80459 GN mutS PE 
162.00 36.41 0.00 
G2JZ74 D alanine aminotransferase OS 
Listeria monocytogenes 
serotype 1 2a strain 10403S GN 
dat PE 3 SV 1 
104.00 15.88 0.03 
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Accessiona Description PLGS 
Score 
Amount 
(fmol) 
St dev 
Q71X61 Glucose 6 phosphate isomerase 
OS Listeria monocytogenes 
serotype 4b strain F2365 GN pgi 
PE 3 SV 1 
188.56 27.29 0.11 
Q8Y4L2 Glycine cleavage system H 
protein OS Listeria 
monocytogenes serovar 1 2a 
strain ATCC BAA 679 EGD 
89.04 n.q n.q 
P21171 Probable endopeptidase p60 OS 
Listeria monocytogenes serovar 
1 2a strain ATCC BAA 679 EGD e 
GN i 
72.54 n.q n.q 
Q71WB8 Elongation factor G Listeria 
monocytogenes serotype 4b 
(strain F2365) 
68.74 n.q n.q 
Q71XG7 Tryptophan--tRNA ligase Listeria 
monocytogenes serotype 4b 
strain F2365 
62.83 n.q n.q 
Q8Y9X7 Uracil DNA glycosylase 1 OS 
Listeria monocytogenes serovar 
1 2a strain ATCC BAA 679 EGD e 
GN ung 
63.53 10.36 0.25 
Q8YAA3 50S ribosomal protein L7 L12 OS 
Listeria monocytogenes serovar 
1 2a strain ATCC BAA 679 EGD e 
GN 
1731.26 313.86 3.82 
Table B 
 
Table 4.3.1_1. A) quantitative analysis of differentially expressed proteins identified in medium 
from Listeria monocytogenes monoculture B) and medium from co-culture with Lactococcus 
lactis. a SwissProt/UniprotK accesion number; the terms nq means below instrumental 
detection limit. 
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In figure 4.3.1-1 data obtained by PLGS analysis are shown, comparing monoculture vs 
coculture of Listeria monocytogenes 
 
Figure 4.3.1-2 Some of differentially expressed proteins of Listeria monocytogenes in BHI 
coculture with Lactococcus lactis identified by Label-free nUPLC-MS/MS 
 
In according with obtained preliminary data, obtained data highlighted, during 
competition, the higher production by Listeria monocytogenes of moonlighting protein 
Enolase (C1KY94) and Glucose 6 Phosphate isomerase (Q71X61) , of Septation ring 
formation regulator EzrA (B8DHE7), involved into cell replication in regulatory 
mechanisms of cell energetics or metabolism and the lower secretion Endopeptidase 
P60 (P21171), protein associated with the cell surface and involved in the process of 
invasion. 
Among these, the most significant result obtained is that Enolase increases by at least 
30 percent during the co-culture. The enolase is an intermediate glycolytic enzyme; 
particularly it converts 2-phosphoglycerate in phosphoenolpyruvate. Regarding its role 
during the co-culture, interesting information underline how the protein secreted into 
the co-culture medium could serve as extracellular signal. Infact it is known that cell 
membrane proteins can act as signals for uptake of nutrients in the medium. 
Furthermore, enolase belongs to a group “moonlight proteins” which are proteins, 
normally cytosolic, secreted on the wall under certain conditions (mainly to increase the 
virulence or improve the adhesion to a host) and released subsequently in the medium 
[29]. Major groups of proteins that moonlight in bacterial virulence include the 
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following: the metabolic enzymes of the glycolytic pathway; enzymes of other metabolic 
pathways such as the glyoxylate cycle, and molecular chaperones and protein-folding 
catalysts. Among the most commonly identified moonlighting virulence functions of 
bacterial proteins are adhesion and modulation of leukocyte activity[112]. 
Moreover, in some pathogens which cause caries, enolase is a molecular target of 
fluoride ions[113]. A number of studies have shown that fluoride inhibits glycolysis and 
reduces acid production[117]. This antimicrobial effect of fluoride has been suggested 
by some to be due to the inhibition of the glycolytic enzyme enolase. 
That is could suggest to monitor the fluoride ions concentration in processing facilities. 
In Table 4.3.1-2 the quantitative analysis of differentially expressed proteins of 
Lactococcus lactis ATCC 11454 in BHI monoculture and in coculture with Listeria 
monocytogens, identified by Label-free nUPLC-MS/MS, are show. 
 
 
Accessiona Description PLGS 
Score 
Amount 
(fmol) 
St dev 
P13068 Lantibiotic nisin A OS Lactococcus 
lactis subsp lactis GN spaN PE 1 SV 1 
600.4 56.00 
 
2.07 
 
P22865 Secreted 45 kDa protein OS 
Lactococcus lactis subsp cremoris 
strain MG1363 GN usp45 PE 1 SV 3 
214.8 nq 
 
nq 
 
Q9CG42 50S ribosomal protein L7 L12 OS 
Lactococcus lactis subsp lactis strain 
IL1403 GN rplL PE 3 SV 1 
735.7 12.68 
 
0.03 
 
Q9CI64 DNA binding protein HU OS 
Lactococcus lactis subsp lactis strain 
IL1403 GN hup PE 3 SV 1 
876.2 nq 
 
nq 
 
Table A 
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Accessiona Description PLGS Score Amount 
(fmol) 
St dev 
D2BNK8 Uncharacterized protein OS 
Lactococcus lactis subsp 
lactis strain KF147 GN usp 
PE 4 SV 1 
456 n.q 
 
n.q 
F2HKA4 Nisin NisinA OS Lactococcus 
lactis subsp lactis strain 
CV56 GN nisA PE 4 SV 1 
2568 n.q n.q 
H5SXJ3 GTNG 0265 lantibiotic 
antimicrobial peptinisin Ade 
OS Lactococcus lactis subsp 
lactis IO 1 GN nisA 
2804 n.q n.q 
P22865 Secreted 45 kDa protein OS 
Lactococcus lactis subsp 
cremoris strain MG1363 GN 
usp45 PE 1 SV 3 
452 20.96 3.46 
P29559 Lantibiotic nisin Z OS 
Lactococcus lactis subsp 
lactis GN nisZ PE 1 SV 1 
2864 768.47 0.51 
Q45RP0 Lantibiotic nisin A Fragment 
OS Lactococcus lactis subsp 
lactis GN nis PE 4 SV 1 
2427 n.q 
 
n.q 
Table B 
Table 4.3.1-2. A) quantitative analysis of differentially expressed protein identified in medium from 
Lactococcus lactis monoculture B) and medium from co-culture with Listeria monocytogenes. a 
SwissProt/UniprotK accesion number; the terms nq means below instrumental detection limit. 
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In figure 4.3.1-3 data obtained by PLGS analysis are shown comparing monoculture vs 
coculture of Lactococcus lactis ATCC 11454. 
 
Figure 4.3.1-3 Some differentially expressed proteins of Lactococcus lactis in BHI coculture with 
Listeria monocytogenes identified by Label-free nUPLC-MS/MS. 
 
The analysis shotgun showed, as important result, that L. lactis produced higher 
amounts of Secreted 45 kDa protein (P22865), protein with hypothetical peptidoglycan 
lytic activity, and switched from lantibiotic Nisin A (P13068) production to Nisin Z 
(Q7DH25) production. It is a very interesting result, already obtained from the 
peptidomics analysis, because there is no evidence in the literature..  
Nisin is a prototype bacteriocin produced by Lactococcus lactis, used as a preservative in 
the food industry for making dairy products,. Nisin A is the first to be discovered[23] and 
other natural variants of this protein are F, Q, U and Z[24].In general each strain of LAB 
owns genetic information related only one protein variant Nisin so usually each strain is 
capable to produce one variant of Nisin active against a wide range of Gram positive 
bacteria. 
Nisin Z differs from Nisin A by just one amino acid residue at position 27 because of a 
single nucleotide substitution. Nisin A contains histidine, and nisin Z asparagine. This 
residue allows to nisin Z a improved solubility at higher pH values respect to nisin A[31]. 
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So, in competition with Listeria monocytogenes, the investigated L. lactis strain produce 
higher amounts of Secreted 45 kDa protein with peptidoglycan lytic activity and the 
selective secretion of NisinZ in order to enhance lantibiotic solubility in less acidic 
environment. The demonstrated features of this L. lactis strain through that proteomics 
approach may help in the additives-free listeriosis prevention. 
 
4.3.2 Validation  
It has been applied label-free proteomics strategy to evaluate the expression profile of 
candidate proteins in milk. In Table 4.3.2-1 and Table 4.3.2-2 the relative quantitative 
analysis of differentially expressed proteins respectively of Listeria monocytogenes and 
Lactococcus lactis ATCC 11454 in milk monoculture and in coculture, identified by Label-
free nUPLC-MS/MS, are show. 
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Accessiona Description PLGS Score Amount  
(fmol) 
St dev 
B8DF04 50S ribosomal protein L7 L12 
OS Listeria monocytogenes 
serotype 4a strain HCC23 GN 
rplL PE 3 SV 1 
168,63 313.86 0.22 
C1KYI3 50S ribosomal protein L7 L12 
OS Listeria monocytogenes 
serotype 4b strain CLIP80459 
GN rplL PE 3 S 
162,26 406.787 0.16 
P21171 Probable endopeptidase p60 
OS Listeria monocytogenes 
serovar 1 2a strain ATCC BAA 
679 EGD e GN i 
126,99 10.88 0.05 
Q724G1 50S ribosomal protein L7 L12 
OS Listeria monocytogenes 
serotype 4b strain F2365 GN 
rplL PE 3 SV 1 
107,26 313.86 0.23 
Q8YAA3 50S ribosomal protein L7 L12 
OS Listeria monocytogenes 
serovar 1 2a strain ATCC BAA 
679 EGD e GN 
137,57 125.67 0.16 
Q71XG7 Tryptophan--tRNA ligase 
Listeria monocytogenes 
serotype 4b strain F2365 
73,83 10.36 0.05 
Table 4.3.2-1A 
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Accessiona Description PLGS Score Amount  
(fmol) 
St dev 
B8DDD3 Glycine cleavage system H 
protein OS Listeria 
monocytogenes serotype 4a 
strain HCC23 GN gcvH PE 3 
42,42 97.49 0.15 
B8DF07 50S ribosomal protein L11 OS 
Listeria monocytogenes 
serotype 4a strain HCC23 GN 
rplK PE 3 SV 1 
816,03 300.74 0.07 
Q02129 ATP 
phosphoribosyltransferase 
Listeria monocytogenes 
serotype 4a strain HCC23 GN 
rplK PE 3 SV 1 
818,28 14.96 0.08 
Q71X61 Glucose 6 phosphate 
isomerase OS Listeria 
monocytogenes serotype 4b 
strain F2365 GN pgi PE 3 SV 1 
88,56 80.73 0.05 
Table 4.3.2-1B 
 
Table 4.3.2-1A)Relative quantitative analysis of differentially expressed proteins identified in 
milk from Listeria monocytogenes monoculture Table 4.3.2-1B) and milk from co-culture with 
Lactococcus lactis a SwissProt/UniprotK accession number; the terms nq means below 
instrumental detection limit. 
Page 87 of 114 
 
Accessiona Description PLGS Score Amount  
(fmol) 
St dev 
P13068 Lantibiotic nisin A OS 
Lactococcus lactis 
subsp lactis GN spaN PE 
1 SV 1 
62,50 23.7 0.1 
Q02129 ATP 
phosphoribosyltransfer
ase Lactococcus lactis 
subsp lactis strain 
IL1403 GN usp45 
818,28 12.4   0.33 
D2BPR6 NADH dehydrogenase 
OS Lactococcus lactis 
subsp lactis strain 
IL1403 GN usp45 
660,72 52.4   0.14  
 Table 4.3.2-2A) 
Accessiona Description PLGS Score Amount  
(fmol) 
St dev 
Q9CDJ1 Putative 
uncharacterized protein 
usp45 OS Lactococcus 
lactis subsp lactis strain 
IL1403 GN usp45 
660,72 20.4 0.23 
D2BNK8 Uncharacterized protein 
OS Lactococcus lactis 
subsp lactis strain KF147 
GN usp PE 4 SV 1 
660,72 n.q n.q 
P29559 Lantibiotic nisin Z OS 
Lactococcus lactis subsp 
lactis GN nisZ PE 1 SV 1 
49,04 168.42 0.08 
 Table 4.3.2-2B) 
Table 4.3.2-2A) Relative quantitative analysis of differentially expressed proteins identified in 
milk from Lactococcus lactis monoculture and (4.3.2-2B)) milk from co-culture with Listeria 
monocytogenes. a SwissProt/UniprotK accession number; the terms nq means below 
instrumental detection limit. 
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Among these, we selected, for their importance, glucose 6-phosphate isomerase of LM 
(Figure 4.3.2-1) and Nisin A-Z of LAC (Figure 4.3.2-2). Glucose 6 Phosphate isomerase 
increases during the condition of competition; it belongs to a “moonlighting 
proteins”group, proteins associated with pathogen higher virulence and proteolytic 
activity. Moreover, shotgun analysis in milk confirmed that, during competition, LAC 
ATCC switched from Nisin A production to Nisin Z. In according with obtained 
preliminary data, the validation in the milk of candidate’s proteins confirms the 
hypothesis regarding the adaptation of LM and LAC ATCC in competition. LAC ATCC 
strain used the selective secretion of NisinZ in order to enhance lantibiotic solubility in 
less acidic environment. 
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Figure 4.3.2-1 Differentially expressed proteins of Listeria monocytogenes in milk coculture with 
Lactococcus lactis identified by Label-free nUPLC-MS/MS 
 
 
Figure 4.3.2-2 Differentially expressed proteins of Lactococcus lactis in milk coculture with 
Listeria mnocytogenes identified by Label-free nUPLC-MS 
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5 CHAPTER 3 
5.1 Microbial Imaging mass spectrometry 
In order to fully understanding molecular interaction pathways that are the basis of the 
microbial competition between Listeria and Lactococcus, we will perform, as next step 
of this project, the metabolic profiling of each bacteria in the context of interacting 
microbial colonies. In fact, an attractive hypothesis suggests that microbes regulate and 
optimize their production of such molecules to kill, limit the growth or modulate the 
metabolism of potential niche competitors for maximal advantage. Traditionally, 
individual microbial metabolites have been targeted using bioactivity-guided 
fractionation. More recent “omics” technologies, such as metabolomics, begin to 
capture molecules on a global scale, but do not distinguish between molecules which 
are always present and molecules with changing spatial distributions, disregarding the 
spatial localization of the molecules within a phenotype and the multifaceted chemical 
exchange within and between microbial cell populations. Matrix-assisted laser 
desorption ionization–time of flight (MALDI-TOF) imaging mass spectrometry (IMS) 
applied directly to microbes on agar-based medium captures global information about 
microbial molecules, allowing for direct correlation of chemotypes to phenotypes. IMS 
technique is capable of simultaneously detecting a wide range of discrete chemical 
signals without the need for chemical tags or labels, this will allow us to probe the native 
chemical environment of each microbial colony and maybe identify novel metabolites 
that were previously undetected by other analytical means. The use of imaging mass 
spectometry, alone or in combination with liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) in order to investigate the metabolic profile of each bacteria 
in the interacting microbial colonies. To realize these aims, I went to the Lab directed by 
prof Pieter Dorrestein in University of California, San Diego 
(http://dorresteinlab.ucsd.edu/Dorrestein_Lab/Welcome.html) for six month during my 
exchanged period, where I learnt to use high throughput instrumentation and I had the 
possibility to use this techniques applied to my specific samples. 
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5.2 Materials and methods 
5.2.1 Culturing and sample preparation for IMS 
Strains Lactococcus lactis ATCC 11454 and Listeria monocytogenes ATCC 19115, 
obtained from the American type Culture Collection, were stored at -80°C in BHI (brain 
heart infusion) broth containing 20% glycerol. Bacteria were streaked on petri dish 
containing BHI agar and incubated at 30°C for 24h. Big colony was picked up and it was 
grown in 5ml of BHI broth at 30°C for 24 hrs. For IMS experiment colony growth was 
initiated by streaking 5 ul overnight growths of Listeria monocytogenes and Lactococus 
lactis at different cell densities (OD Listeria <OD Lacto) on the prepared agar petri dish. 
Bacterial colonies were allowed to grow for 48 h at 30° C before transferring the co-
culturing experiment to a MSP 96 MALDI anchor plate (Bruker, Daltonics)[25]. All 
analysis were made on the biological and technical triplicate 
5.2.2 Spray Technique 
The sample was dried at 40°C overnight and transferred to the enclosed spray chamber 
of a Bruker ImagePrep device (Bruker Daltonics, Billerica, MA, USA). The plate was 
covered with matrix by spraying 2.5 mL of a matrix solution in 60 consecutive cycles in a 
nitrogen atmosphere. Each cycle comprised three steps: 2 s spraying, 10 s incubation 
times, and 40 s of active drying using nitrogen gas. After 30 cycles, the sample was 
turned by 180° to avoid inhomogeneous matrix deposition. Matrix solutions were of 20 
mg/mL dissolved in ACN/MeOH/H2O (70:25:5, v/v/v) with a 1:1 mixture of α-cyano-4- 
hydroxycinnamic acid (CHCA) and 2,5- dihydroxybenzoic acid (DHB).  
5.2.3 MALDI IMS 
All data were collected on an UltraFlex Speed MALDI-TOF/TOF mass spectrometer 
(Bruker-Daltonics) equipped with a Nd:YAG smartbeam2 laser (Bruker Daltonics). 
Samples were dried in vacuo for 30 min prior to the analysis [8].  
 
5.2.4 Data analysis 
The datasets were analysed by using the FlexImaging software. FlexImaging (Bruker-
Daltonics) was used to set up and control the acquisition. Spatial resolution was set to 
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500 μm. For each section the acquisition was performed in reflectron positive mode. All 
reflectron acquisitions were performed in the range of 100–6000 Da with voltages of 25 
and 21.7 kV for the first and second ion extraction stages, respectively and 9 kV for the 
lens, 26.3 kV for reflector 1, 13.8 kV for reflector 2, and a laser power of 30%. One 
hundred shots per spectrum were accumulated for the reflectron mode (20 shots 
random walk) at a frequency of 500 Hz. Standard signals of 1–6 kDa were used to 
calibrate for the reflectron mode. After acquisition, the data were analyzed using the 
FlexImaging software. The resulting mass spectrum was filtered manually in 0.5–3.0-
absorbance unit increments with individual colors assigned to the specific masses. Ions 
of interest were identified by the use of tandem mass spectrometry. 
5.2.5 Molecules identification by LC MS/MS 
5.2.5.1   Extraction Procedure and LC MS/MS analysis 
General chemical extraction of the samples was performed sliced into small pieces (0.1 
cmx0.1cm) and extracted with 10 mL of methanol plus 0.1% formic acid. The solvent 
was separated from agar pieces by filtration and concentrated in vacuo. Extracts were 
resuspended in 1 mL of methanol and centrifuged prior to analysis LC-MS/MS. Mass 
spectrometry was performed using a Bruker Daltronics Maxis qTOF mass spectrometer 
equipped with a standard electrospray ionization source. The mass spectrometer was 
tuned by infusion of Tuning Mix ES-TOF (Agilent Technologies, Santa Clara, CA,USA) at a 
3 μL/min flow rate. For accurate mass measurements, a wick saturated with hexakis 
(1H,1H,3H-tetrafluoropropoxy)phophazene ions (Synquest Laboratories, Alachua, FL, 
USA; m/z 922.0098) located within the source was used for lock mass internal 
calibration. Samples were introduced by a Thermo Scientific UltraMate 3000 Dionex 
ultraperformance liquid chromatograph (UPLC) using a 20-μL injection volume. 
Methanol/FA extracts were separated using a Phenomenex (Torrance, CA, USA) Kinetex 
2.6 μm C18 (30×2.10 mm) UPLC column. A linear water acetonitrile gradient (from98:2 
to 2:98 water/acetonitrile) containing 0.1% formic acid was utilized. The flow rate was 
0.5 mL/min. The mass spectrometer was operated in data-dependent positive ion mode, 
automatically switching between full-scan MS and MS/ MS acquisitions. Full-scan MS 
spectra (m/z 50 to 2000) were acquired, and the top 10 most intense ions in a particular 
scan were fragmented using collision-induced dissociation at 35 eV for +1 ions and 25 eV 
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for +2 ions in the collision cell. All analysis were made on the biological and technical 
triplicate 
5.2.5.2  Data Analysis  
Visualization of ion intensity was optimized to highlight differences between samples 
being compared. Structural verification of ions putatively identified in IMS was 
performed manually by comparing the exact mass from the LCMS/ MS. LC-MS/MS data 
analysis was performed using Bruker Daltronics DataAnalysis v4.1 (Build 362.7). 
Lockmass internal calibration using hexakis(1H,1H,3H-tetrafluoropropoxy) phosphazene 
ions (Synquest Laboratories; m/z 922.0098) was applied. Extracted ion chromatograms 
(EICs) using the exact mass of a metabolite of interest were created. The MS/MS spectra 
from these EICs were manually compared with previously reported data.  
5.2.5.3  Database search 
The MS/MS spectra are searched against GNPS spectral libraries (Global Natural 
Products Social molecular network), seeding putative node matches in the molecular 
networks.Comparing the MS2 spectra of the unknown metabolite with a library of MS2 
spectra generated from structurally characterized metabolites. Herein, this comparison 
is based upon the similarity cosine scoring of MS/MS spectra. Networks are visualized 
online in-browser or exported for third-party visualization software such as 
Cytoscape[26]. GNPS is an open-access knowledge base for community-wide 
organization and sharing of raw, processed and identified tandem mass (MS/MS) 
spectrometry data[27].GNPS has the largest collection of publicly accessible natural 
product and metabolomics MS/MS data sets and is the only infrastructure where public 
data sets can be reanalyzed together and compared with each other.To date, GNPS has 
made 272 public GNPS data sets openly available, which comprise >30,000 MS runs with 
~84 million MS/MS spectra. Parameters used for the database search were: parent mass 
tolerance (Parent mass peak tolerance) set to 2 Da; Ion Tolerance (MS2 peak tolerance) 
0.5 Da, Min Pairs Cos (Cosine score threshold to make a match) 0.5; Min Matched Peaks 
(Minimum matched peaks to make a match) set to 6. Library search spectral is based on 
the comparison upon the similarity cosine scoring of MS/MS spectra. 
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5.2.5.4  Molecular network creation and visualization 
 
 
Figure5.2.5.4-1 Molecular network creation and visualization. 
 
In figure 5.2.5.4-1 molecular networks are show. Molecular networks are constructed 
from the alignment of MS/MS spectra to one another. Edges connecting nodes (MS/MS 
spectra) are defined by a modified cosine scoring scheme that determines the similarity 
of two MS/MS spectra with scores ranging from 0 (totally dissimilar) to 1 (completely 
identical). MS/MS spectra are also searched against GNPS spectral libraries, seeding 
putative node matches in the molecular networks. Networks are visualized online in-
browser or exported for third-party visualization software such as Cytoscape31. (b) An 
example alignment between three MS/MS spectra of compounds with structural 
modifications that are captured by modification-tolerant spectral matching used in 
variable dereplication and molecular networking. (c) In-browser molecular network 
visualization enables users to interactively explore molecular networks without 
requiring any external software. To date, >11,000 molecular networks have been 
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analyzed using this feature. Within this interface, (i) users are able to define cohorts of 
input data and correspondingly, nodes within the network are represented as pie charts 
to visualize spectral count differences for each molecule across cohorts. (ii) Node labels 
indicate matches made to GNPS spectral libraries. These matches provide users a 
starting point to annotate unidentified MS/MS spectra within the network. (iii) To 
facilitate identification of unknowns, users can display MS/MS spectra in the right panels 
by clicking on the nodes in the network, giving direct interactive access to the underlying 
MS/MS peak data. Furthermore, alignments between spectra are visualized between 
spectra in the top right and bottom right panels to gain insight as to what underlying 
characteristics of the molecule could elicit fragmentation perturbations [27]. 
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5.3 Statistical analysis  
A molecular network was created using the online workflow at GNPS. The data was 
filtered by removing all MS/MS peaks within +/- 17 Da of the precursor m/z. MS/MS 
spectra were window filtered by choosing only the top 6 peaks in the +/- 50Da window 
throughout the spectrum. The data was then clustered with MS-Cluster with a parent 
mass tolerance of 2.0 Da and a MS/MS fragment ion tolerance of 0.5 Da to create 
consensus spectra . Further, consensus spectra that contained less than 2 spectra were 
discarded. A network was then created where edges were filtered to have a cosine score 
above 0.7 and more than 6 matched peaks. Further edges between two nodes were 
kept in the network if and only if each of the nodes appeared in each other's respective 
top 10 most similar nodes. The spectra in the network were then searched against 
GNPS' spectral libraries. The library spectra were filtered in the same manner as the 
input data. All matches kept between network spectra and library spectra were required 
to have a score above 0.7 and at least 6 matched peaks. 
 
 
Table 5.3-1 Parameters table 
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5.4 Results and Discussion 
Specialized metabolites are chemical compounds with a low molecular weight produced 
by many microorganisms growing on substrates. These compounds are not essential for 
microorganism growth but their natural productions have certain significant. They could 
play an important role in mechanisms of competition, antagonism and self-defence 
mechanisms against other living organisms to allow the microorganism to occupy the 
niche and utilize the food. These metabolites are key components in cell-cell 
interactions as quorum sensors, virulent factor and natural product. Traditionally, 
individual microbial metabolites have been targeted using bioactivity-guided 
fractionation. More recent “omics” technologies, such as metabolomics, begin to 
capture molecules on a global scale, but do not distinguish between molecules which 
are always present and molecules with changing spatial distributions, disregarding the 
spatial localization of the molecules within a phenotype and the multifaceted chemical 
exchange within and between microbial cell populations. Matrix-assisted laser 
desorption ionization–time of flight (MALDI-TOF) imaging mass spectrometry (IMS) 
applied directly to microbes on agar-based medium captures global information about 
microbial molecules, allowing for direct correlation of chemotypes to phenotypes. IMS 
technique is capable of simultaneously detecting a wide range of discrete chemical 
signals without the need for chemical tags or labels, this will allow us to probe the native 
chemical environment of each microbial colony and maybe identify novel metabolites 
that were previously undetected by other analytical means[118]. 
In this work, we have chosen to study mediators of bacterial interaction using the 
advance technology IMS in combination with liquid chromatography-tandem mass 
spectrometry (LC-MS/MS).   
In figure 5.4-1 we report the average reflectron positive mode MALDI-TOF MS spectra of 
colonies of Listeria monocytogenes and Lactococcus lactis growing alone versus the 
microbial interaction between L. monocytogenes and Lactococcus lactis.   
In the mass spectrum obtained from colonies the signals are much concentrated in the 
low mass range, in agreement with the production of molecules with a low molecular 
weight by bacteria in order to counteract other living organisms. 
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Figure 5.4-1 Avarage reflectron positive mode MALDI-TOF MS spectra of live colony IMS of 
microbial interaction between LM and LAC. Colours peaks represent signals m/z selected for the 
analysis IMS 
 
IMS data analysis was performed using Bruker Daltronics FlexImaging v3.0. Visualization 
of ion intensity was optimized to highlight differences between samples being 
compared. We focused our attention on signals that were specific for condition of 
microbial competition in order to identify molecules that could be involved in this 
mechanism. In figure 5.4-2A is reported the optical image of colonies of Listeria 
monocytogenes (LM) and Lactococcus lactis (LAC) growing alone (ctrl) and the 
interaction between Listeria monocytogens and Lactococcus lactis. In figure 5.4-2B, C 
and D show the localization of signals at m/z = 250.33, m/z = 334.37 and m/z = 284.08 
on colonies of each bacteria. All three signals are specific for the interaction between 
Listeria monocytogenes and Lactococcus lactis and they are more abundant in the 
bottom part of the colony of Lactococcus lactis, the part of the colony that is closest to 
the colony of Listeria monocytogenes. Signals have a specific localization in the colony of 
Lactococcus lactis.  
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Figure 5.4-2 A) the optical image of colonies of Listeria monocytogenes (LM) and Lactococcus 
lactis (LAC) growing alone (ctrl) and the interaction between Listeria monocytogens and 
Lactococcus lactis. We evaluated two different distance of interaction (0.5-1 cm) ; B,C,D) 
Microbial IMS images of selected signals. Ion intensity colour scaling indicates that the highest 
naturally released molecule is located at the bacterial interface. 
LAC 
LM 
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In order to identify these signals, structural verification of ions putatively identified in 
IMS was performed manually by comparing the exact mass from the LC MS/ MS. The 
MS/MS spectra are searched against GNPS spectral libraries (Global Natural Products 
Social molecular network).  
GNPS is a data-driven platform for the storage, analysis, and knowledge dissemination 
of MS/MS spectra that enables community sharing of raw spectra, continuous 
annotation of deposited data, and collaborative curation of reference spectra (referred 
to as spectral libraries) and experimental data (organized as data sets). GNPS provides 
the ability to analyze a data set and to compare it to all publicly available data. At 
present 221,083 MS/MS spectra from 18,163 unique compounds are used for searches 
in GNPS. GNPS can be used for molecular networking, a spectral correlation and 
visualization approach that can detect sets of spectra from related molecules, even 
when the spectra themselves are not matched to any known compounds[119]. 
Molecular networks are constructed from the alignment of MS/MS spectra to one 
another. Edges connecting nodes (MS/MS spectra) are defined by a modified cosine 
scoring scheme that determines the similarity of two MS/MS spectra with scores ranging 
from 0 (totally dissimilar) to 1 (completely identical). In table 5.4-1 compounds 
identified by GNPS are showed. 
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Table 5.4-1. View all compounds identified by GNPS database. The table showed the library 
matches, metadata is associated with the library spectra including the compound name, a CAS 
number if it is a commercial compound and a PUBMED ID correlating to the published data. The 
score shown correlates to the cosine scoring function where 1 is an exact match. 
 
Among results obtained, comparing the exact mass from the LC MS/ MS with ions 
putatively identified in IMS, we focused our attention on three compounds that are 
specific of the bacterial interaction and also with a relevant biological function.  
The signal m/z 250.33 (261.00m/z +Na+) corresponds to Cyclo-(Leu-leu); the signal m/z 
334.37 (311.00 m/z+Na+) to Cyclo-(Phe-Tyr) and the signal m/z 284.08 (261.12m/z+Na+) 
to Cyclo-(L-Phe-L-4-Hyp). Interestingly, the mass difference between variant found by 
IMS analysis and LC MS/MS is approximately 23 for each three signals , which could 
correlate to the addition of Sodium. 
In figure 5.4-3 molecular networks of the three compounds identified, constructed from 
the alignment of MS/MS spectra.  
Page 102 of 114 
 
 
A 
 
Page 103 of 114 
 
B 
 
 
 
 
 
 
 
Page 104 of 114 
 
C 
 
Figure 5.4-3 Molecular network creation and visualization A) Cyclo-(Leu-leu);B) Cyclo-(Phe-Tyr); 
C) Cyclo-(L-Phe-L-4-Hyp). Node labels indicate matches made to GNPS spectral libraries. To 
facilitate identification of unknowns, users can display MS/MS spectra in the right panels by 
clicking on the nodes in the network, giving direct interactive access to the underlying MS/MS 
peak data. 
 
These compounds are cyclic peptides, isolated by Lactobacilli, with a biological 
activity[4] 
The first compound belongs to the family of Diketopiperazines. Diketopiperazines are 
smallest cyclic peptides known with different bacterial function: antibiotic biosynthesis, 
production of virulence factors, exopolysaccharide biosynthesis, bacterial aggregation, 
plasmid conjugal transfer and transition into the stationary phase[120]. They represent 
the novel family of signalling compounds identified in cell-free supernatants of several 
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gram-positive cultures. The precise role played by diketopiperazines in bacterial cell-to-
cell communication has yet to be established, but their potential to act as auto-inducer 
antagonists, preventing bacterial biofilm formation[121].  
Cyclo-(Phe-Tyr) is a compound produced by Lactobacillus plantarum CRL 778 for the first 
time [122]. It is an active secondary metabolites with lysozyme activity, phagocytic 
actvity and bactericidal activity[123]. 
The third compound is Cyclo-(L-Phe-L-4-Hyp) produced by L. Plantarum[124]. Cyclic 
dipeptides possess antibacterial activities. Due to their chiral, rigid, and functionalized 
structures, they bind to a large variety of receptors with high affinity, giving a broad 
range of biological activities. 
There are evidence in the literature that these cyclic peptides identified are involved in 
bacterial cel-to cell communication but their potential role role played in the mechanism 
has to be yet established[125].  
Our hypothesis is that these cyclic peptide identified could mediate the quorum sensing. 
Quorum sensing is a cell density-dependent signal transduction system, which controls a 
variety of the physiological behaviour in bacteria, such as virulence, conjugation, biofilm 
formation, motility and antibiotic production. During quorum sensing, bacteria produce 
and secrete the small signal molecules outside the cell to recognize the population 
density. In particular, it was documentated that, Gram+ bacteria use small peptide 
(cyclic peptide) to interact, to communicate, and to regulate gene expression in a 
coordinated manner in response to different environments[126]. In gram-positive 
bacteria, quorum sensing is involved in the regulation of genetic competence in Bacillus 
subtilis[127] and Streptococcus pneumonia[128], virulence and biofilm formation in 
Staphylococcus aureus[129], and conjugation in Enterococcus faecalis[130] and in the 
production of antimicrobial peptides, including bacteriocins and lantibiotics, in lactic 
acid bacteria[131]. 
So, in agreement with the literacture and with our previous studies, these cyclic 
peptides, identified with imaging mass spectrometry, could have a role in antibiotic 
production and in particular in inducing of the transcription of gene coding for Nisin, the 
bacteriocin produceded by Lactococcus lactis. 
In this part of the project microbial competition between Listeria monocytogenes and 
Lactococcus lactis was monitored by combination of IMS and LC MS/MS in order to 
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investigate the metabolic profile of each bacteria colony in the interacting microbial 
colonies. Several interesting compounds, uniquely expressed during interaction of 
microbial colonies, were obtained, as it has been discussed above. So, Imaging Mass 
Spectrometry could be well validated method to investigate “online molecular 
conversation between bacteria” to increase knowledge and strategy in food safety, and 
could be consider a valid tool to use directly on food. 
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6 Conclusion 
Most environments host an amazingly diverse collection of microbial species.  
Microbial species exist in constant competition with one another for suitable ecological 
niches to support their survival and growth. The populations eject into environment 
compounds that kill or limit the growth of competing strains or species can promote 
niche monopolization. The microbial competition is a mechanism that tends to eliminate 
one of the populations from their common habitat, especially when competition is 
focused on a single resource and when the populations do not otherwise interact. The 
same happens in food, and it could be possible to explore this social communication to 
improve food safety. 
There are no doubts as to whether that food safety is essential for food security and 
food quality. Food safety and quality represent a global importance, particularly because 
it affects the health but also economy and trade due to the strict rules for food 
exportation. Indeed, some countries such as the US, Russia, China, require for the export 
of animal products certification 'Listeria free'; this represents a major economic loss for 
Italian industries of typical products. So, it is mandatory for prevention and control of 
infectious diseases to have facilities that are able to quickly produce reliable, highly 
specific and sensible tools that allow on one hand and adequate sanitary surveillance 
and to obtain effective operative tools such as proteomics. 
Proteomics represents a real challenge in this field, because it is able to produce rapid 
methods to investigate the modification or the presence or absence of targeted proteins 
in complex food including raw materials and matrices.  
Proteomics should guide us to functional proteomics in food. Proteomics, metabolomics 
methods are presented as effective tools for identification of cellular biomarkers for 
adaptive behavior of pathogenic microorganisms under different conditions such as cold 
and heat stress, osmotic, high hydrostatic pressure, and other stress factors. Proteins 
are fundamental and integral food components, both nutritionally and functionally. 
Thus, the application of proteomics technologies will contribute to the following 
research areas of food science and technology, which includes evaluation of safety, 
body distribution and metabolism of food ingredients, detection and control of food 
spoilage and the presence of pathogenic microorganisms. Furthermore, proteomes of 
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certain food (wheat, fish) can be used to identify the origin of a particular food or its 
quality during the food processing. Proteome and/or metabolome of starter cultures in 
fermentation processes (beer, cheese, etc.) can be also used to predict the quality of the 
fermented end-product. 
These results that we obtained will be useful for developing new biological strategies to 
control the bacteria for undesirable bacterial activities in cheese and dairy products. We 
expect that our proteomic investigation of dairy products will support food industries to 
produce safe and quality food, to ensure food safety during whole shelf-life of products 
in order to solve the problem of growth of potential pathogens in products further 
increase the quality of this product. 
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